LifePoint Health, Inc. (LPNT)

BRENTWOOD, Tenn.--(BUSINESS WIRE)--LifePoint Health, Inc. (NASDAQ: LPNT) today announced results for the first quarter ended March 31, 2018. The following highlights the Company’s results of operations as presented in accordance with U.S. generally accepted accounting principles (“GAAP”) for the first quarter ended March 31, 2018: Same-hospital revenues totaled $1,603.1 million, an increase of 0.4% compared to the same period last year; Net loss totaled $5.3 million; Diluted loss per share attributable to LifePoint Health, Inc. stockholders was $0.22; and Net cash provided by operating activities totaled $100.6 million, an increase of $8.9 million, or 9.7%, compared to the same period last year. The Company’s results of operations for the first quarters ended March 31, 2018 and 2017, included the following non-operational adjustments: For the first quarter of 2018, the Company recognized a net charge of $72.7 million, or $1.44 loss per diluted share, primarily related to impairment losses recognized in connection with the Company’s entry into definitive agreements to sell the assets of three hospital campuses located in Louisiana. For the first quarter of 2017, the Company recognized a net gain of $25.9 million, or $0.39 earnings per diluted share, related to the transfer of certain of the Company’s home health agencies and hospices to In-Home Healthcare Partnership (“IHHP”), a joint venture with LHC Group, Inc., which the Company does not consolidate, and the settlement of a contingent liability previously established in connection with a prior hospital acquisition. Excluding the non-operational adjustments listed above, highlights of the Company’s results of operations, as adjusted on a non-GAAP basis, for the first quarter ended March 31, 2018, were as follows: Adjusted net income totaled $51.7 million; Adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders were $1.22; and Adjusted EBITDA totaled $188.5 million. Additional information regarding adjusted net income, adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders, and adjusted EBITDA, including uses by management and others, and a reconciliation to comparable GAAP measures of financial performance, is set forth under the section titled “Unaudited Supplemental Information.” For the first quarter ended March 31, 2018, the Company’s same-hospital revenues increased $6.9 million, or 0.4%, to $1,603.1 million, compared to $1,596.2 million for the same period last year. The increase in the Company’s same-hospital revenues consisted of a 2.6% increase in same-hospital revenues per equivalent admission, partially offset by a 2.2% decrease in same-hospital equivalent admissions for the first quarter ended March 31, 2018, compared to the same period last year. When adjusted to exclude the impact of the transfer of the Company’s home health and hospice service lines to IHHP, the Company’s same-hospital revenues increased $15.3 million, or 1.0%, for the first quarter ended March 31, 2018, compared to the same period last year. When adjusted to exclude the aforementioned first quarter 2018 and 2017 non-operational adjustments, adjusted net income for the first quarter ended March 31, 2018, was $51.7 million, compared to adjusted net income of $47.8 million for the same period last year, and adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the first quarter ended March 31, 2018, were $1.22, compared to adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders of $1.07 for the same period last year. Adjusted EBITDA for the first quarter ended March 31, 2018, was $188.5 million, or 11.8% of revenues, compared to $195.6 million, or 12.0% of revenues, for the same period last year. This decrease was partially the result of the recognition of $3.2 million less in Medicare and Medicaid electronic health record (“EHR”) incentive payments during the first quarter of 2018 compared to the same period last year. The Company’s EHR incentive payments have gradually decreased and ultimately ended in 2017. Commenting on the results, William F. Carpenter III, Chairman and Chief Executive Officer of LifePoint Health, said, “We are pleased with the solid first quarter 2018 results, which demonstrate the successful execution of our strategy. Our continued focus on quality of care, operational excellence and effective cost management helped drive sequential margin expansion and strong cash flow during the quarter, and we also continued to utilize our financial strength to return capital to shareholders. Looking ahead, we remain focused on our strategic priorities to continue creating value for shareholders.” A listen-only simulcast, as well as a 30-day replay, of LifePoint Health’s first quarter 2018 conference call will be available on line at www.lifepointhealth.net/investor-relations today, Friday, May 4, 2018, beginning at 10:00 a.m. Eastern Time. LifePoint Health (NASDAQ: LPNT) is a leading healthcare company dedicated to Making Communities Healthier®. Through its subsidiaries, it provides quality inpatient, outpatient and post-acute services close to home. LifePoint owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in 22 states. It is the sole community healthcare provider in the majority of the non-urban communities it serves. More information about the Company can be found at www.LifePointHealth.net. All references to “LifePoint,” “LifePoint Health” or the “Company” used in this release refer to affiliates or subsidiaries of LifePoint Health, Inc. Important Legal Information. Certain statements contained in this release are based on current management expectations and are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to qualify for the safe harbor protections from liability provided by the Private Securities Litigation Reform Act of 1995. Numerous factors exist which may cause results to differ from these expectations. Many of the factors that will determine our future results are beyond our ability to control or predict with accuracy. Such forward-looking statements reflect the current expectations and beliefs of the management of LifePoint, are not guarantees of performance and are subject to a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ from those described in the forward-looking statements. These forward-looking statements may also be subject to other risk factors and uncertainties, including without limitation: (i) the effects of actions to amend or impede the implementation of, or repeal and replace, the Affordable Care Act, the possible enactment of additional federal or state healthcare reforms and possible changes in healthcare reform laws and other federal, state or local laws or regulations affecting the healthcare industry including the timing of the implementation of reform; (ii) the extent to which states support increases, decreases or changes in Medicaid programs, or alter the provision of healthcare to state residents through regulation or otherwise; (iii) reductions in, or delays in receiving, Medicare or Medicaid payments (including increased recoveries made by Recovery Audit Contractors (RACs) and similar governmental agents); (iv) payer mix pressures as a result of aging populations in non-urban communities; (v) reductions in reimbursements from commercial payers and risks associated with consolidation among commercial insurance companies and shifts to insurance plans with narrow networks, high deductibles or high co-payments; (vi) the continued viability of our operations through joint venture entities, the largest of which is Duke LifePoint Healthcare, our partnership with a wholly controlled affiliate of Duke University Health Systems, Inc.; (vii) our ability to successfully integrate acquired facilities into our ongoing operations and to achieve the anticipated financial results and synergies from such acquisitions, individually or in the aggregate; (viii) the deterioration in the collectability of “bad debt” and “patient due” accounts, and the number of individuals without insurance coverage (or who are underinsured) who seek care at our facilities; (ix) industry emphasis on value-based purchasing and bundled payment arrangements; (x) whether our efforts to reduce the cost of providing healthcare while increasing the quality of care are successful; (xi) the ability to attract, recruit or employ and retain qualified physicians, nurses, medical technicians and other healthcare professionals and the increasing costs associated with doing so, including the direct and indirect costs associated with employing physicians and other healthcare professionals; (xii) the loss of certain physicians in markets where such a loss can have a disproportionate impact on our facilities in such market; (xiii) the application and enforcement of increasingly stringent and complex laws and regulations governing our operations and healthcare generally (and changing interpretations of applicable laws and regulations), related enforcement activity and the potentially adverse impact of known and unknown government investigations, litigation and other claims that may be made against us; (xiv) risks due to cybersecurity attack or security breach and our access to personal information of patients and employees; (xv) our ability to successfully implement standardized systems throughout the company; (xvi) payer controls designed to reduce inpatient services; (xvii) our ability to generate sufficient cash flow to fund all of our capital expenditure programs and commitments; (xviii) adverse events in states where a large portion of our revenues are concentrated; (xix) liabilities resulting from potential malpractice and related legal claims brought against our facilities or the healthcare providers associated with, or employed by, such facilities or affiliated entities; (xx) our increased dependence on third parties to provide purchasing, revenue cycle and payroll services and information technology and their ability to do so effectively; (xxi) our ability to acquire healthcare facilities on favorable terms and the business risks, unknown or contingent liabilities and other costs associated therewith; (xxii) changes in interpretations, assumptions, and expectations regarding the Tax Cuts and Jobs Act, including additional guidance that may be issued by federal and state taxing authorities; and (xxiii) those other risks and uncertainties described from time to time in our filings with the Securities and Exchange Commission. Therefore, our future results may differ materially from those described in this release. LifePoint undertakes no obligation to update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. LIFEPOINT HEALTH, INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Dollars in millions, except per share amounts Less: Net income attributable to noncontrolling interests and redeemable noncontrolling interests (Loss) earnings per share attributable to LifePoint Health, Inc. stockholders: LIFEPOINT HEALTH, INC. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS Dollars in millions March 31,2018 Dec. 31,2017 Land Three Months EndedMarch 31, Adjustments to reconcile net (loss) income to net cash provided by operating activities: Increase (decrease) in cash from operating assets and liabilities,net of effects from acquisitions and divestitures: Three Months Ended March 31, % Change (1) Consolidated information includes the results of the Company’s same-hospital operations and the results of Rockdale Medical Center located in Conyers, Georgia, which was sold effective October 1, 2017. (2) Management and investors use equivalent admissions as a general measure of combined inpatient and outpatient volume. The Company computes equivalent admissions by multiplying admissions (inpatient volumes) by the Outpatient factor. The equivalent admissions computation “equates” outpatient revenue to the volume measure (admissions) used to measure inpatient volume resulting in a general measure of combined inpatient and outpatient volume. (3) The sum of gross inpatient revenue and gross outpatient revenue divided by gross inpatient revenue. (4) Same-hospital information includes the results of the Company’s health support center and the same 71 hospital campuses operated during the three months ended March 31, 2018 and 2017. Same-hospital information excludes the Company’s hospitals that have previously been disposed. LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATION From time to time, the Company incurs certain non-recurring gains or losses that are non-operational in nature and that it does not consider relevant in assessing its ongoing operating performance. When significant, LifePoint’s management and Board of Directors typically exclude these gains or losses when evaluating the Company’s operating performance and in certain instances when evaluating performance for incentive compensation purposes. Additionally, the Company believes that some investors and equity analysts exclude these or similar items when evaluating the Company’s current or future operating performance and in making informed investment decisions regarding the Company. Accordingly, the Company provides adjusted net income and adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders as a supplement to the comparable GAAP measures of net (loss) income and diluted (loss) earnings per share attributable to LifePoint Health, Inc. stockholders, respectively. Adjusted net income and adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders should not be considered measures of financial performance in accordance with GAAP, and the items excluded from adjusted net income and adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders are significant components in understanding and assessing financial performance. Adjusted net income and adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders should not be considered in isolation or as an alternative to net (loss) income or diluted (loss) earnings per share attributable to LifePoint Health, Inc. stockholders as presented in the unaudited condensed consolidated financial statements. The following table reconciles net (loss) income as reflected in the unaudited condensed consolidated statements of operations to adjusted net income (in millions): Three Months Ended March 31, The following table reconciles diluted (loss) earnings per share attributable to LifePoint Health, Inc. stockholders as reflected in the unaudited condensed consolidated statements of operations to adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders: Three Months Ended March 31, LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATION (Continued) Adjusted EBITDA is defined by the Company as earnings before depreciation and amortization; interest expense, net; other non-operating losses (gains), net; provision for income taxes; and net income attributable to noncontrolling interests and redeemable noncontrolling interests. LifePoint’s management and Board of Directors use adjusted EBITDA to evaluate the Company’s operating performance and as a measure of performance for incentive compensation purposes. LifePoint’s credit facilities use adjusted EBITDA, subject to further permitted adjustments, for certain financial covenants. The Company believes adjusted EBITDA is a measure of performance used by some investors, equity analysts, rating agencies and lenders to make informed decisions as to, among other things, the Company’s ability to incur and service debt and make capital expenditures. In addition, multiples of current or projected adjusted EBITDA are used by some investors and equity analysts to estimate current or prospective enterprise value. Adjusted EBITDA should not be considered a measure of financial performance in accordance with GAAP, and the items excluded from adjusted EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA should not be considered in isolation or as an alternative to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the condensed consolidated financial statements as an indicator of financial performance. Because adjusted EBITDA is not a measurement determined in accordance with GAAP and is susceptible to varying calculations, adjusted EBITDA as presented may not be comparable to other similarly titled measures of other companies. The following table reconciles net (loss) income as reflected in the unaudited condensed consolidated statements of operations to adjusted EBITDA (in millions): % ofRevenues % ofRevenues

BRENTWOOD, Tenn.--(BUSINESS WIRE)--LifePoint Health, Inc. (NASDAQ: LPNT) today announced results for the fourth quarter and year ended December 31, 2017. Fourth Quarter 2017 The following highlights the Company’s results of operations as presented in accordance with U.S. generally accepted accounting principles (“GAAP”) for the fourth quarter ended December 31, 2017: Same-hospital revenues totaled $1,490.3 million, a decrease of 5.2% compared to the same period last year; Net loss totaled $27.0 million; Diluted loss per share attributable to LifePoint Health, Inc. stockholders was $0.70; and Net cash provided by operating activities totaled $178.2 million, an increase of $75.7 million, or 73.9%, compared to the same period last year. Included in the Company’s results of operations for the fourth quarter ended December 31, 2017, were the following non-operational adjustments: $72.6 million increase recorded to the provision for doubtful accounts, or $1.15 loss per diluted share, as a result of a change in the Company’s accounting estimate of the collectability of accounts receivable identified by the Company’s management during the process of installing new systems and developing enhanced analytical procedures in order to centralize, standardize and refine its estimation processes to more precisely estimate the collectability of accounts receivable at a more detailed and disaggregated level; $4.8 million in severance costs, or $0.08 loss per diluted share, associated with a reduction in force at the Company’s corporate headquarters; $43.2 million aggregate impairment charges, or $0.69 loss per diluted share, to write-down the carrying values of certain long-lived assets at two of the Company’s hospitals; and $18.0 million decrease in the provision for income taxes, or $0.45 earnings per diluted share, related to the estimated impact of the Tax Cuts and Jobs Act on the Company’s deferred tax positions. When adjusted to exclude the four non-operational adjustments listed above, highlights of the Company’s normalized results of operations on a non-GAAP basis for the fourth quarter ended December 31, 2017, were as follows: Normalized same-hospital revenues totaled $1,562.9 million, a decrease of 0.6% compared to the same period last year; Normalized net income totaled $31.3 million; Normalized diluted earnings per share attributable to LifePoint Health, Inc. stockholders were $0.77; and Normalized EBITDA totaled $181.9 million. Additional information regarding normalized net income, normalized diluted earnings per share attributable to LifePoint Health, Inc. stockholders, Adjusted EBITDA and Normalized EBITDA, including uses by management and others, and a reconciliation to comparable GAAP measures of financial performance, is set forth under the section titled “Unaudited Supplemental Information.” A supplemental presentation providing additional commentary on the Company’s normalized results of operations for the fourth quarter ended December 31, 2017 and years ended December 31, 2017 and 2016, can be found on the Company’s website at www.lifepointhealth.net/investor-relations. For the fourth quarter ended December 31, 2017, the Company’s normalized same-hospital revenues decreased $9.6 million, or 0.6%, to $1,562.9 million, compared to $1,572.5 million for the same period last year. The decrease in the Company’s normalized same-hospital revenues was primarily attributable to the transfer of its home health and hospice service lines to In-Home Healthcare Partnership (“IHHP”), a joint venture with LHC Group, Inc., which the Company does not consolidate. When adjusted to exclude the impact of the transfer of its home health and hospice service lines to IHHP, the Company’s normalized same-hospital revenues increased $6.4 million, or 0.4%, for the fourth quarter ended December 31, 2017, compared to the same period last year. When adjusted to exclude the four aforementioned fourth quarter 2017 non-operational adjustments, normalized net income for the fourth quarter ended December 31, 2017, was $31.3 million, compared to net income of $46.6 million for the same period last year, and normalized diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the fourth quarter ended December 31, 2017, were $0.77, compared to diluted earnings per share attributable to LifePoint Health, Inc. stockholders of $1.07 for the same period last year. Normalized EBITDA for the fourth quarter ended December 31, 2017, was $181.9 million, or 11.6% of normalized revenues, compared to $196.8 million, or 12.3% of revenues, for the same period last year. This decrease was primarily the result of the recognition of $8.8 million less in Medicare and Medicaid electronic health record (“EHR”) incentive payments during the current quarter compared to the same period last year. Full Year 2017 The following highlights the Company’s results of operations as presented in accordance with U.S. GAAP for the year ended December 31, 2017: Same-hospital revenues totaled $5,941.3 million, a decrease of 0.8% compared to the prior year; Net income totaled $112.9 million; Diluted earnings per share attributable to LifePoint Health, Inc. stockholders were $2.51; and Net cash provided by operating activities totaled $471.6 million, an increase of $36.4 million, or 8.4%, compared to the prior year. In addition to the four aforementioned fourth quarter 2017 non-operational adjustments, the Company’s results of operations for the full years ended December 31, 2017 and 2016, included the following additional non-operational adjustments: $28.8 million in aggregate net gains, or $0.35 earnings per diluted share, recognized throughout the first three quarters of 2017, related to the transfer of the Company’s home health agencies and hospices to IHHP; $18.0 million gain, or $0.28 earnings per diluted share, recognized in the first quarter of 2017, related to the settlement of a contingent liability previously established in connection with a prior hospital acquisition; $12.7 million net impairment loss, or $0.32 loss per diluted share, recognized in the third quarter of 2017, for the write-off of allocated goodwill, partially offset by gains on the sale of property, equipment and certain other assets, in connection with the disposal of Rockdale Medical Center (“Rockdale”) located in Conyers, Georgia, effective October 1, 2017; $24.7 million in charges for cardiology-related lawsuits, or $0.36 loss per diluted share, recognized during the year ended December 31, 2016; $22.0 million in debt transaction costs, or $0.32 loss per diluted share, recognized during the year ended December 31, 2016; and $1.2 million impairment loss, or $0.02 loss per diluted share, for the write-off of certain capital assets during the year ended December 31, 2016. When adjusted to exclude all full year 2017 non-operational adjustments, highlights of the Company’s normalized results of operations on a non-GAAP basis for the year ended December 31, 2017, were as follows: Normalized same-hospital revenues totaled $6,013.9 million, an increase of 0.4% compared to the prior year; Normalized net income totaled $158.6 million; Normalized diluted earnings per share attributable to LifePoint Health, Inc. stockholders were $3.63; and Normalized EBITDA totaled $745.7 million. For the year ended December 31, 2017, the Company’s normalized same-hospital revenues increased $21.7 million, or 0.4%, to $6,013.9 million, compared to $5,992.2 million for the prior year. When adjusted to exclude the impact of the transfer of its home health and hospice service lines to IHHP, the Company’s normalized same-hospital revenues increased $71.8 million, or 1.2%, for the year ended December 31, 2017, compared to the prior year. When adjusted to exclude all non-operational adjustments impacting the years ended December 31, 2017 and 2016, normalized net income for the years ended December 31, 2017 and 2016, was $158.6 million and $161.8 million, respectively, and normalized diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the years ended December 31, 2017 and 2016, were $3.63 and $3.52, respectively. Normalized EBITDA for the year ended December 31, 2017, was $745.7 million compared to $746.5 million for the prior year. This decrease was primarily the result of the recognition of $19.2 million less in Medicare and Medicaid EHR incentive payments for the current year compared to the prior year, partially offset by effective cost management. Commenting on the results, William F. Carpenter III, Chairman and Chief Executive Officer of LifePoint Health, said, “In 2017, we continued to focus on our strategic priorities and took a number of steps to support LifePoint Health’s position as a leader in the delivery of healthcare. Our fourth quarter financial performance, on a normalized basis, was in line with our expectations. Looking ahead to 2018, we are focused on driving margin improvement across all hospitals, particularly in those recently acquired where we have significant opportunity, maintaining our operating discipline and effectively managing costs and utilizing our financial strength to return capital to shareholders.” 2018 Guidance The Company also issued the following estimated guidance for 2018: The Company’s 2018 guidance contains a number of assumptions, including: Same-hospital revenue growth excludes the 2017 results of Rockdale. Diluted EPS includes an estimated benefit of $0.69 to $0.78 earnings per diluted share as a result of the Tax Cuts and Jobs Act. 2018 guidance excludes, if applicable, the estimated impact of items that are non-operational in nature, including items such as, but not limited to, gains or losses on early debt retirements, impairments of long-lived assets, impairments of goodwill, changes as a result of the adoption of new accounting standards and share repurchases. 2018 guidance excludes the estimated impact of future acquisitions or disposals, if applicable. 2018 guidance is subject to certain risks, including those as set forth in the Company’s “Important Legal Information.” A listen-only simulcast, as well as a 30-day replay, of LifePoint Health’s fourth quarter and year-end 2017 conference call will be available on line at www.lifepointhealth.net/investor-relations today, Friday, February 23, 2018, beginning at 10:00 a.m. Eastern Time. LifePoint Health (NASDAQ: LPNT) is a leading healthcare company dedicated to Making Communities Healthier®. Through its subsidiaries, it provides quality inpatient, outpatient and post-acute services close to home. LifePoint owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in 22 states. It is the sole community healthcare provider in the majority of the non-urban communities it serves. More information about the Company can be found at www.LifePointHealth.net. All references to “LifePoint,” “LifePoint Health” or the “Company” used in this release refer to affiliates or subsidiaries of LifePoint Health, Inc. Important Legal Information. Certain statements contained in this release, including LifePoint’s guidance for the year ended December 31, 2018, are based on current management expectations and are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to qualify for the safe harbor protections from liability provided by the Private Securities Litigation Reform Act of 1995. Numerous factors exist which may cause results to differ from these expectations. Many of the factors that will determine our future results are beyond our ability to control or predict with accuracy. Such forward-looking statements reflect the current expectations and beliefs of the management of LifePoint, are not guarantees of performance and are subject to a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ from those described in the forward-looking statements. These forward-looking statements may also be subject to other risk factors and uncertainties, including without limitation: (i) the effects of actions to amend or impede the implementation of, or repeal and replace, the Affordable Care Act, the possible enactment of additional federal or state healthcare reforms and possible changes in healthcare reform laws and other federal, state or local laws or regulations affecting the healthcare industry including the timing of the implementation of reform; (ii) the extent to which states support increases, decreases or changes in Medicaid programs, or alter the provision of healthcare to state residents through regulation or otherwise; (iii) reductions in, or delays in receiving, Medicare or Medicaid payments (including increased recoveries made by Recovery Audit Contractors (RACs) and similar governmental agents); (iv) payer mix pressures as a result of aging populations in non-urban communities; (v) reductions in reimbursements from commercial payers and risks associated with consolidation among commercial insurance companies and shifts to insurance plans with narrow networks, high deductibles or high co-payments; (vi) the continued viability of our operations through joint venture entities, the largest of which is Duke LifePoint Healthcare, our partnership with a wholly controlled affiliate of Duke University Health Systems, Inc.; (vii) our ability to successfully integrate acquired facilities into our ongoing operations and to achieve the anticipated financial results and synergies from such acquisitions, individually or in the aggregate; (viii) the deterioration in the collectability of “bad debt” and “patient due” accounts, and the number of individuals without insurance coverage (or who are underinsured) who seek care at our facilities; (ix) industry emphasis on value-based purchasing and bundled payment arrangements; (x) whether our efforts to reduce the cost of providing healthcare while increasing the quality of care are successful; (xi) the ability to attract, recruit or employ and retain qualified physicians, nurses, medical technicians and other healthcare professionals and the increasing costs associated with doing so, including the direct and indirect costs associated with employing physicians and other healthcare professionals; (xii) the loss of certain physicians in markets where such a loss can have a disproportionate impact on our facilities in such market; (xiii) the application and enforcement of increasingly stringent and complex laws and regulations governing our operations and healthcare generally (and changing interpretations of applicable laws and regulations), related enforcement activity and the potentially adverse impact of known and unknown government investigations, litigation and other claims that may be made against us; (xiv) risks due to cybersecurity attack or security breach and our access to personal information of patients and employees; (xv) our ability to successfully implement standardized systems throughout the company; (xvi) payer controls designed to reduce inpatient services; (xvii) our ability to generate sufficient cash flow to fund all of our capital expenditure programs and commitments; (xviii) adverse events in states where a large portion of our revenues are concentrated; (xix) liabilities resulting from potential malpractice and related legal claims brought against our facilities or the healthcare providers associated with, or employed by, such facilities or affiliated entities; (xx) our increased dependence on third parties to provide purchasing, revenue cycle and payroll services and information technology and their ability to do so effectively; (xxi) our ability to acquire healthcare facilities on favorable terms and the business risks, unknown or contingent liabilities and other costs associated therewith; (xxii) changes in interpretations, assumptions, and expectations regarding the Tax Cuts and Jobs Act, including additional guidance that may be issued by federal and state taxing authorities; and (xxiii) those other risks and uncertainties described from time to time in our filings with the Securities and Exchange Commission. Therefore, our future results may differ materially from those described in this release. LifePoint undertakes no obligation to update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. Revenues before provision for doubtful accounts (Loss) income before income taxes (Benefit) provision for income taxes Less: Net income attributable to noncontrolling interests and redeemable noncontrolling interests Net (loss) income attributable to LifePoint Health, Inc. Weighted average shares outstanding - basic Weighted average shares outstanding - diluted (Loss) earnings per share attributable to LifePoint Health, Inc. stockholders: Accounts receivable, less allowances for doubtful accounts of $1,020.2 and $891.2 at December 31, 2017 and December 31, 2016, respectively Adjustments to reconcile net (loss) income to net cash provided by operating activities: Increase (decrease) in cash from operating assets and liabilities, net of effects from acquisitions and divestitures: LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATION From time to time, the Company incurs certain non-recurring gains or losses that are non-operational in nature and that it does not consider relevant in assessing its ongoing operating performance. When significant, LifePoint’s management and Board of Directors typically exclude these gains or losses when evaluating the Company’s operating performance and in certain instances when evaluating performance for incentive compensation purposes. Additionally, the Company believes that some investors and equity analysts exclude these or similar items when evaluating the Company’s current or future operating performance and in making informed investment decisions regarding the Company. Accordingly, the Company provides normalized net income and normalized diluted earnings per share attributable to LifePoint Health, Inc. stockholders as a supplement to the comparable GAAP measures of net (loss) income and diluted (loss) earnings per share attributable to LifePoint Health, Inc. stockholders, respectively. Normalized net income and normalized diluted earnings per share attributable to LifePoint Health, Inc. stockholders should not be considered measures of financial performance in accordance with GAAP, and the items excluded from normalized net income and normalized diluted earnings per share attributable to LifePoint Health, Inc. stockholders are significant components in understanding and assessing financial performance. Normalized net income and normalized diluted earnings per share attributable to LifePoint Health, Inc. stockholders should not be considered in isolation or as an alternative to net (loss) income or diluted (loss) earnings per share attributable to LifePoint Health, Inc. stockholders as presented in the condensed consolidated financial statements. The following table reconciles net (loss) income as reflected in the unaudited condensed consolidated statements of income to normalized net income (in millions): The following table reconciles diluted (loss) earnings per share attributable to LifePoint Health, Inc. stockholders as reflected in the unaudited condensed consolidated statements of income to normalized diluted earnings per share attributable to LifePoint Health, Inc. stockholders: Normalized diluted earnings per share attributable to LifePoint Health, Inc. stockholders LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATION (Continued) Adjusted EBITDA is defined by the Company as earnings before depreciation and amortization; interest expense, net; other non-operating losses, net; (benefit) provision for income taxes; and net income attributable to noncontrolling interests and redeemable noncontrolling interests (when applicable for the periods presented). Additionally, Normalized EBITDA excludes the impact of the $72.6 million increase recorded to the provision for doubtful accounts during the fourth quarter of 2017 as a result of a change in the Company’s accounting estimate of the collectability of accounts receivable, $4.8 million in severance costs recognized during the fourth quarter of 2017, and $24.7 million in charges related to cardiology-related lawsuits recognized during the year ended December 31, 2016. LifePoint’s management and Board of Directors use Adjusted EBITDA and Normalized EBITDA to evaluate the Company’s operating performance and as a measure of performance for incentive compensation purposes. LifePoint’s credit facilities use Adjusted EBITDA, subject to further permitted adjustments, for certain financial covenants. The Company believes Adjusted EBITDA and Normalized EBITDA are measures of performance used by some investors, equity analysts, rating agencies and lenders to make informed decisions as to, among other things, the Company’s ability to incur and service debt and make capital expenditures. In addition, multiples of current or projected Adjusted EBITDA and Normalized EBITDA are used by some investors and equity analysts to estimate current or prospective enterprise value. Adjusted EBITDA and Normalized EBITDA should not be considered as measures of financial performance in accordance with GAAP, and the items excluded from Adjusted EBITDA and Normalized EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA and Normalized EBITDA should not be considered in isolation or as an alternative to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the condensed consolidated financial statements as an indicator of financial performance. Because Adjusted EBITDA and Normalized EBITDA are not measurements determined in accordance with GAAP and are susceptible to varying calculations, Adjusted EBITDA and Normalized EBITDA as presented may not be comparable to other similarly titled measures of other companies. The following table reconciles net (loss) income as reflected in the unaudited condensed consolidated statements of income to Adjusted EBITDA and Normalized EBITDA (in millions): Less: Net income attributable to noncontrolling interests and redeemable noncontrolling interests Adjust: Depreciation and amortization LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATION (Continued) The following table reconciles net income to Estimated Adjusted EBITDA as presented for the Company’s 2018 guidance ranges (in millions):

BRENTWOOD, Tenn.--(BUSINESS WIRE)--LifePoint Health, Inc. (NASDAQ: LPNT) today announced results for the third quarter and nine months ended September 30, 2017. For the third quarter ended September 30, 2017, consolidated revenues were $1,576.0 million compared with $1,585.7 million for the same period last year. Net income for the third quarter ended September 30, 2017, was $29.9 million compared with net income of $41.2 million for the same period last year. Net income for the third quarter ended September 30, 2017, includes a net non-operating gain before income taxes of $3.7 million, which is comprised of a $16.4 million gain related to the transfer of certain of the Company’s home health agencies and hospices to an unconsolidated joint venture partnership, and an impairment loss of $12.7 million for the write-off of allocated goodwill in connection with the sale of a hospital located in Conyers, Georgia. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the third quarter ended September 30, 2017, were $0.67 per share compared with $0.92 per share for the same period last year. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the third quarter ended September 30, 2017, were negatively impacted by $0.13 per share as a result of the net impact of the aforementioned non-operating gain and loss. When adjusted to exclude these items, adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the third quarter ended September 30, 2017, were $0.80 per share. For the nine months ended September 30, 2017, consolidated revenues were $4,801.0 million compared with $4,758.8 million for the same period last year. Net income for the first nine months of 2017 was $139.9 million, compared with net income of $85.2 million for the same period last year. Net income for the nine months ended September 30, 2017, includes a net non-operating gain before income taxes of $34.1 million, which is comprised of an $18.0 million gain related to the settlement of a contingent liability previously established in connection with a prior hospital acquisition, $28.8 million in gains related to the transfer of certain of the Company’s home health agencies and hospices to an unconsolidated joint venture partnership, and an impairment loss of $12.7 million for the write-off of allocated goodwill in connection with the sale of a hospital located in Conyers, Georgia. Net income for the nine months ended September 30, 2016, includes charges of $24.7 million related to cardiology-related lawsuits and non-operating losses in the aggregate of $23.2 million, of which $22.0 million is related to debt transaction costs and $1.2 million is related to an impairment loss for the write-off of certain capital assets. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the nine months ended September 30, 2017, were $3.16 per share compared with $1.78 per share for the same period last year. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the nine months ended September 30, 2017, were positively impacted by $0.29 per share as a result of the net impact of the aforementioned non-operating gains and losses. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the nine months ended September 30, 2016, were negatively impacted by a total of $0.68 per share as a result of a combination of the aforementioned non-operating losses in the aggregate and the cardiology-related lawsuits. When adjusted to exclude these various items, adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the first nine months of 2017 increased to $2.87 per share compared with $2.46 per share for the same period last year. Additional information regarding adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders, including uses by management and others and a reconciliation to diluted earnings per share attributable to LifePoint Health, Inc. stockholders, is set forth under the section titled “Unaudited Supplemental Information.” Finally, Adjusted EBITDA for the third quarter ended September 30, 2017, was $176.0 million compared with $188.0 million for the same period last year, and Adjusted Normalized EBITDA for the nine months ended September 30, 2017, was $563.8 million compared with $549.7 million for the same period last year. Adjusted Normalized EBITDA for the nine months ended September 30, 2016, excludes the impact of $24.7 million in charges related to cardiology-related lawsuits. The Company noted that Adjusted EBITDA results for the third quarter ended September 30, 2017, were $14.0 million below its expectations. Industry-wide general market conditions accounted for approximately $4.0 million of this amount, while the remaining $10.0 million was attributable to the performance of its class of 2016 acquired hospitals, $4.0 million of which was related to period over period revenue adjustments, including cost report settlements and certain payments related to supplemental payment programs, that negatively impacted the Company’s results. Additional information regarding Adjusted EBITDA and Adjusted Normalized EBITDA, including definitions, uses by management and others and a reconciliation to net income, is set forth in this release under the section titled “Unaudited Supplemental Information.” Commenting on the results, William F. Carpenter III, Chairman and Chief Executive Officer of LifePoint Health, said, “Excluding the four hospitals that represent our 2016 acquired class, the balance of our portfolio performed well in the face of industry-wide headwinds. While margins in the 2016 class are not yet improving at the pace we had planned, margins for the remainder of our portfolio grew to 13.0% in the quarter. Although the timing of the results we will achieve in the 2016 class has shifted, I remain excited about their opportunities for growth. We are confident that through the continued execution of our strategy, we will drive enhanced shareholder value while continuing to provide our communities high quality care.” The Company’s revised guidance excludes the fourth quarter operations associated with its recently sold hospital located in Conyers, Georgia, and the impact of the $34.1 million net non-operating gain recognized in the first nine months of 2017, as well as the future impact of items that are non-operational in nature, including items such as, but not limited to, gains or losses related to the transfer of certain of the Company’s home health agencies and hospices to an unconsolidated joint venture partnership, gains or losses on early debt retirements, impairments of long-lived assets and share repurchases. Additionally, guidance excludes the estimated impact of future acquisitions or disposals, if applicable. Finally, this guidance is subject to certain risks including those as set forth in the Company’s “Important Legal Information.” The Company’s normalized volume and rate guidance has been adjusted to exclude the full year 2017 and 2016 impact of the operations associated with the Company’s recently sold hospital located in Conyers, Georgia, and its February 1, 2016, acquisition of a hospital system in Columbia, South Carolina. In addition, the Company announced that its Board of Directors has authorized a new stock repurchase plan for the repurchase of up to $200.0 million in outstanding shares of its common stock. Under the new stock repurchase plan announced today, the Company may repurchase its common stock from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions and other considerations. The Company’s repurchases may be executed using open market purchases, privately negotiated transactions, accelerated share repurchase programs or other transactions. A listen-only simulcast, as well as a 30-day replay, of LifePoint Health’s third quarter 2017 conference call will be available on line at www.lifepointhealth.net/investor-relations today, Friday, October 27, 2017, beginning at 10:00 a.m. Eastern Time. LifePoint Health (NASDAQ: LPNT) is a leading healthcare company dedicated to Making Communities Healthier®. Through its subsidiaries, it provides quality inpatient, outpatient and post-acute services close to home. LifePoint owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in 22 states. It is the sole community healthcare provider in the majority of the non-urban communities it serves. More information about the Company can be found at www.LifePointHealth.net. All references to “LifePoint,” “LifePoint Health” or the “Company” used in this release refer to affiliates or subsidiaries of LifePoint Health, Inc. Important Legal Information. Certain statements contained in this release, including LifePoint’s revised Guidance for the year ended December 31, 2017, are based on current management expectations and are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to qualify for the safe harbor protections from liability provided by the Private Securities Litigation Reform Act of 1995. Numerous factors exist which may cause results to differ from these expectations. Many of the factors that will determine our future results are beyond our ability to control or predict with accuracy. Such forward-looking statements reflect the current expectations and beliefs of the management of LifePoint, are not guarantees of performance and are subject to a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ from those described in the forward-looking statements. These forward-looking statements may also be subject to other risk factors and uncertainties, including without limitation: (i) the effects related to the enactment and implementation of healthcare reform, the possible repeal and replacement of the Affordable Care Act, the possible enactment of additional federal or state healthcare reforms and possible changes in healthcare reform laws and other federal, state or local laws or regulations affecting the healthcare industry including the timing of the implementation of reform; (ii) the extent to which states support increases, decreases or changes in Medicaid programs, or alter the provision of healthcare to state residents through regulation or otherwise; (iii) delays in receiving payments for services provided, reductions in Medicare or Medicaid payments (including increased recoveries made by Recovery Audit Contractors (RACs) and similar governmental agents), compared to the timing of expanded coverage; (iv) reductions in reimbursements from commercial payors and risks associated with consolidation among commercial insurance companies and shifts to insurance plans with narrow networks, high deductibles or high co-payments; (v) the continued viability of our operations through joint venture entities, the largest of which is Duke LifePoint Healthcare, our partnership with a wholly controlled affiliate of Duke University Health Systems, Inc.; (vi) our ability to successfully integrate acquired facilities into our ongoing operations and to achieve the anticipated financial results and synergies from such acquisitions, individually or in the aggregate; (vii) the deterioration in the collectability of “bad debt” and “patient due” accounts, and the number of individuals without insurance coverage (or who are underinsured) who seek care at our facilities; (viii) industry emphasis on value-based purchasing and bundled payment arrangements; (ix) whether our efforts to reduce the cost of providing healthcare while increasing the quality of care are successful; (x) the ability to attract, recruit or employ and retain qualified physicians, nurses, medical technicians and other healthcare professionals and the increasing costs associated with doing so, including the direct and indirect costs associated with employing physicians and other healthcare professionals; (xi) the loss of certain physicians in markets where such a loss can have a disproportionate impact on our facilities in such market; (xii) the application and enforcement of increasingly stringent and complex laws and regulations governing our operations and healthcare generally (and changing interpretations of applicable laws and regulations), related enforcement activity and the potentially adverse impact of known and unknown government investigations, litigation and other claims that may be made against us; (xiii) risks due to cybersecurity attack or security breach and our access to personal information of patients and employees; (xiv) our ability to successfully implement enterprise-wide information technology systems; (xv) payor controls designed to reduce inpatient services; (xvi) our ability to generate sufficient cash flow to fund all of our capital expenditure programs and commitments; (xvii) adverse events in states where a large portion of our revenues are concentrated; (xviii) liabilities resulting from potential malpractice and related legal claims brought against our facilities or the healthcare providers associated with, or employed by, such facilities or affiliated entities; (xix) our increased dependence on third parties to provide purchasing, revenue cycle and payroll services and information technology and their ability to do so effectively; (xx) our ability to acquire healthcare facilities on favorable terms and the business risks, unknown or contingent liabilities and other costs associated therewith; and (xxi) those other risks and uncertainties described from time to time in our filings with the Securities and Exchange Commission. Therefore, our future results may differ materially from those described in this release. LifePoint undertakes no obligation to update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. LIFEPOINT HEALTH, INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Dollars in millions, except per share amounts Three Months Ended September 30, September 30, % ofRevenues % ofRevenues % ofRevenues % ofRevenues Revenues before provision for doubtful accounts Other non-operating (gains) losses, net LIFEPOINT HEALTH, INC. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS Dollars in millions Sept. 30,2017 Dec. 31,2016 Accounts receivable, less allowances for doubtful accounts of $939.0 and $891.2 at September 30, 2017 and December 31, 2016, respectively LIFEPOINT HEALTH, INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Dollars in millions Three Months Ended September 30, Adjustments to reconcile net income to net cash provided by operating activities: Increase (decrease) in cash from operating assets and liabilities, net of effects from acquisitions and divestitures: LIFEPOINT HEALTH, INC. UNAUDITED STATISTICS September 30, September 30, %Change %Change - % LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATIONDollars in millions Adjusted EBITDA is defined by the Company as earnings before depreciation and amortization; interest expense, net; other non-operating (gains) losses, net; provision for income taxes; and net income attributable to noncontrolling interests and redeemable noncontrolling interests. Additionally, Adjusted Normalized EBITDA excludes the impact of $24.7 million in charges related to cardiology-related lawsuits recognized during the first quarter of 2016. LifePoint’s management and Board of Directors use Adjusted EBITDA and Adjusted Normalized EBITDA to evaluate the Company’s operating performance and as a measure of performance for incentive compensation purposes. LifePoint’s credit facilities use Adjusted EBITDA, subject to further permitted adjustments, for certain financial covenants. The Company believes Adjusted EBITDA and Adjusted Normalized EBITDA are measures of performance used by some investors, equity analysts, rating agencies and lenders to make informed decisions as to, among other things, the Company’s ability to incur and service debt and make capital expenditures. In addition, multiples of current or projected Adjusted EBITDA and Adjusted Normalized EBITDA are used by some investors and equity analysts to estimate current or prospective enterprise value. Adjusted EBITDA and Adjusted Normalized EBITDA should not be considered as measures of financial performance under U.S. generally accepted accounting principles (“GAAP”), and the items excluded from Adjusted EBITDA and Adjusted Normalized EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA and Adjusted Normalized EBITDA should not be considered in isolation or as an alternative to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the condensed consolidated financial statements as an indicator of financial performance. Because Adjusted EBITDA and Adjusted Normalized EBITDA are not measurements determined in accordance with GAAP and are susceptible to varying calculations, Adjusted EBITDA and Adjusted Normalized EBITDA as presented may not be comparable to other similarly titled measures of other companies. The following table reconciles net income as reflected in the unaudited condensed consolidated statements of operations to Adjusted EBITDA and Adjusted Normalized EBITDA: % ofRevenues % ofRevenues % ofRevenues % ofRevenues Less: Net income attributable to noncontrolling interests and redeemable noncontrolling interests Adjust: Depreciation and amortization Other non-operating (gains) losses, net Net income attributable to noncontrolling interests and redeemable noncontrolling interests Add: Cardiology-related lawsuits LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATION (Continued)Dollars in millions The following table reconciles net income to Estimated Adjusted EBITDA as presented for the Company’s updated guidance ranges: From time to time, the Company incurs certain non-recurring gains or losses that are normally nonoperational in nature and that it does not consider relevant in assessing its ongoing operating performance. When significant, LifePoint’s management and Board of Directors typically exclude these gains or losses when evaluating the Company’s operating performance and in certain instances when evaluating performance for incentive compensation purposes. Additionally, the Company believes that some investors and equity analysts exclude these or similar items when evaluating the Company’s current or future operating performance and in making informed investment decisions regarding the Company. Accordingly, the Company provides adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders as a supplement to its comparable GAAP measure of diluted earnings per share attributable to LifePoint Health, Inc. Adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders should not be considered as a measure of financial performance under GAAP, and the items excluded from adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders are significant components in understanding and assessing financial performance. Adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders should not be considered in isolation or as an alternative to diluted earnings per share attributable to LifePoint Health, Inc. stockholders as presented in the condensed consolidated financial statements. The following table reconciles diluted earnings per share attributable to LifePoint Health, Inc. stockholders as reflected in the unaudited condensed consolidated statements of operations to adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders: Adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders

BRENTWOOD, Tenn.--(BUSINESS WIRE)--LifePoint Health, Inc. (NASDAQ: LPNT) today announced results for the second quarter and six months ended June 30, 2017. For the second quarter ended June 30, 2017, consolidated revenues were $1,594.8 million compared with $1,592.4 million for the same period last year. Net income for the second quarter ended June 30, 2017, was $46.0 million, up $25.9 million, compared with net income of $20.1 million for the same period last year. Net income for the second quarter ended June 30, 2017, includes a non-operating gain of approximately $4.5 million, $2.8 million net of income taxes, related to the transfer of certain of the Company’s home health agencies and hospices to an unconsolidated joint venture partnership. Net income for the second quarter ended June 30, 2016, includes a non-operating loss of $22.0 million, or $13.7 million net of income taxes, for debt transaction costs related to the extinguishment of certain existing debt instruments and the issuance of certain new debt instruments. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the second quarter ended June 30, 2017, increased to $1.03 per share compared with $0.38 per share for the same period last year. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the second quarter ended June 30, 2017, were positively impacted by $0.07 per share as a result of the aforementioned non-operating gain. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the second quarter ended June 30, 2016, were negatively impacted by $0.31 per share as a result of the aforementioned non-operating loss. When adjusted to exclude these two items, adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the second quarter ended June 30, 2017, increased to $0.96 per share compared with $0.69 per share for the same period last year. For the six months ended June 30, 2017, consolidated revenues were $3,225.0 million compared with $3,173.1 million for the same period last year. Net income for the first half of 2017 was $110.0 million, up $66.0 million, compared with net income of $44.0 million for the same period last year. Net income for the six months ended June 30, 2017, includes non-operating gains in the aggregate of $30.4 million, or $19.0 million net of income taxes, of which $18.0 million, or $11.3 million net of income taxes, is related to the settlement of a contingent liability previously established in connection with a prior hospital acquisition, and $12.4 million, or $7.7 million net of income taxes, is related to the transfer of certain of the Company’s home health agencies and hospices to an unconsolidated joint venture partnership. Net income for the six months ended June 30, 2016, includes non-operating losses in the aggregate of $23.2 million, or $14.5 million net of income taxes, of which $22.0 million, or $13.7 million net of income taxes, is related to debt transaction costs and $1.2 million, or $0.8 million net of income taxes, is related to an impairment charge for the write-off of certain capital assets. Additionally, net income for the six months ended June 30, 2016, includes charges of $24.7 million, or $15.5 million net of income taxes, related to cardiology-related lawsuits. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the six months ended June 30, 2017, increased to $2.49 per share compared with $0.87 per share for the same period last year. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the six months ended June 30, 2017, were positively impacted by $0.46 per share as a result of the aforementioned non-operating gains in the aggregate. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the six months ended June 30, 2016, were negatively impacted by a total of $0.68 per share as a result of a combination of the aforementioned non-operating losses in the aggregate and the cardiology-related lawsuits. When adjusted to exclude these various items, adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the first half of 2017 increased to $2.03 per share compared with $1.55 per share for the same period last year. Additional information regarding adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders, including uses by management and others and a reconciliation to diluted earnings per share attributable to LifePoint Health, Inc. stockholders, is set forth under the section titled “Unaudited Supplemental Information.” Finally, Adjusted EBITDA for the second quarter ended June 30, 2017, increased 9.6% to $192.2 million compared with $175.4 million for the same period last year, and Adjusted Normalized EBITDA for the six months ended June 30, 2017, increased 7.2% to $387.8 million compared with $361.7 million for the same period last year. Adjusted Normalized EBITDA for the six months ended June 30, 2016, excludes the impact of $24.7 million in charges related to cardiology-related lawsuits. Additional information regarding Adjusted EBITDA and Adjusted Normalized EBITDA, including definitions, uses by management and others and a reconciliation to net income, is set forth in this release under the section titled “Unaudited Supplemental Information.” Commenting on the results, William F. Carpenter III, Chairman and Chief Executive Officer of LifePoint Health, said, “We are pleased to deliver another quarter of solid results with EBITDA growth and expanded margins both year-over-year and sequentially. Our longstanding operating discipline continues to be integral to our success even while the volume environment remains challenging. We are successfully integrating recently acquired hospitals and health systems and remain committed to our strategic priorities of quality and service, growth, operational excellence and talent development at every location to drive long-term value for our shareholders.” $6.425 - $6.5 billion $775 - $795 million Guidance excludes the impact of $30.4 million in other non-operating gains recognized in the first half of 2017 as well as the future impact of items that are non-operational in nature, including items such as, but not limited to, gains or losses related to the transfer of certain of the Company’s home health agencies and hospices to an unconsolidated joint venture partnership, gains or losses on early debt retirements, impairments of long-lived assets and share repurchases. Additionally, guidance excludes the estimated impact of future acquisitions or disposals, if applicable. Finally, this guidance is subject to certain risks including those as set forth in the Company’s “Important Legal Information.” A listen-only simulcast, as well as a 30-day replay, of LifePoint Health’s second quarter 2017 conference call will be available on line at www.lifepointhealth.net/investor-relations today, Tuesday, August 1, 2017, beginning at 10:00 a.m. Eastern Time. LifePoint Health (NASDAQ: LPNT) is a leading healthcare company dedicated to Making Communities Healthier®. Through its subsidiaries, it provides quality inpatient, outpatient and post-acute services close to home. LifePoint owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in 22 states. It is the sole community healthcare provider in the majority of the non-urban communities it serves. More information about the Company can be found at www.LifePointHealth.net. All references to “LifePoint,” “LifePoint Health” or the “Company” used in this release refer to affiliates or subsidiaries of LifePoint Health, Inc. Important Legal Information. Certain statements contained in this release, including LifePoint’s revised Guidance for the year ended December 31, 2017, are based on current management expectations and are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to qualify for the safe harbor protections from liability provided by the Private Securities Litigation Reform Act of 1995. Numerous factors exist which may cause results to differ from these expectations. Many of the factors that will determine our future results are beyond our ability to control or predict with accuracy. Such forward-looking statements reflect the current expectations and beliefs of the management of LifePoint, are not guarantees of performance and are subject to a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ from those described in the forward-looking statements. These forward-looking statements may also be subject to other risk factors and uncertainties, including without limitation: (i) the effects related to the enactment and implementation of healthcare reform, the possible repeal and replacement of the Affordable Care Act, the possible enactment of additional federal or state healthcare reforms and possible changes in healthcare reform laws and other federal, state or local laws or regulations affecting the healthcare industry including the timing of the implementation of reform; (ii) the extent to which states support increases, decreases or changes in Medicaid programs, or alter the provision of healthcare to state residents through regulation or otherwise; (iii) delays in receiving payments for services provided, reductions in Medicare or Medicaid payments (including increased recoveries made by Recovery Audit Contractors (RACs) and similar governmental agents), compared to the timing of expanded coverage; (iv) reductions in reimbursements from commercial payors and risks associated with consolidation among commercial insurance companies and shifts to insurance plans with narrow networks, high deductibles or high co-payments; (v) the continued viability of our operations through joint venture entities, the largest of which is Duke LifePoint Healthcare, our partnership with a wholly controlled affiliate of Duke University Health Systems, Inc.; (vi) our ability to successfully integrate acquired facilities into our ongoing operations and to achieve the anticipated financial results and synergies from such acquisitions, individually or in the aggregate; (vii) the deterioration in the collectability of “bad debt” and “patient due” accounts, and the number of individuals without insurance coverage (or who are underinsured) who seek care at our facilities; (viii) industry emphasis on value-based purchasing and bundled payment arrangements; (ix) whether our efforts to reduce the cost of providing healthcare while increasing the quality of care are successful; (x) the ability to attract, recruit or employ and retain qualified physicians, nurses, medical technicians and other healthcare professionals and the increasing costs associated with doing so, including the direct and indirect costs associated with employing physicians and other healthcare professionals; (xi) the loss of certain physicians in markets where such a loss can have a disproportionate impact on our facilities in such market; (xii) the application and enforcement of increasingly stringent and complex laws and regulations governing our operations and healthcare generally (and changing interpretations of applicable laws and regulations), related enforcement activity and the potentially adverse impact of known and unknown government investigations, litigation and other claims that may be made against us; (xiii) risks due to cybersecurity attack or security breach and our access to personal information of patients and employees; (xiv) our ability to successfully implement enterprise-wide information technology systems; (xv) payor controls designed to reduce inpatient services; (xvi) our ability to generate sufficient cash flow to fund all of our capital expenditure programs and commitments; (xvii) adverse events in states where a large portion of our revenues are concentrated; (xviii) liabilities resulting from potential malpractice and related legal claims brought against our facilities or the healthcare providers associated with, or employed by, such facilities or affiliated entities; (xix) our increased dependence on third parties to provide purchasing, revenue cycle and payroll services and information technology and their ability to do so effectively; (xx) our ability to acquire healthcare facilities on favorable terms and the business risks, unknown or contingent liabilities and other costs associated therewith; and (xxi) those other risks and uncertainties described from time to time in our filings with the Securities and Exchange Commission. Therefore, our future results may differ materially from those described in this release. LifePoint undertakes no obligation to update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. LIFEPOINT HEALTH, INC.UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONSDollars in millions, except per share amounts June 30, June 30, % of Revenues % of Revenues % of Revenues % of Revenues Revenues before provision for doubtful accounts (gains) losses LIFEPOINT HEALTH, INC.UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETSDollars in millions 2017 2016 Accounts receivable, less allowances for doubtful accounts of $950.9 and $891.2 at June 30, 2017 and December 31, 2016, respectively LIFEPOINT HEALTH, INC.UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWSDollars in millions Three Months Ended June 30, Six Months Ended June 30, Adjustments to reconcile net income to net cash provided by operating activities: Increase (decrease) in cash from operating assets and liabilities, net of effects from acquisitions and divestitures: LIFEPOINT HEALTH, INC.UNAUDITED STATISTICS June 30, June 30, Change Change - % (1) Consolidated information includes the results of the Company’s health support center, its same-hospital operations and the results of Providence Hospitals, a two-campus hospital system, located in Columbia, South Carolina, which the Company acquired effective February 1, 2016. (2) Management and investors use equivalent admissions as a general measure of combined inpatient and outpatient volume. The Company computes equivalent admissions by multiplying admissions (inpatient volumes) by the outpatient factor (the sum of gross inpatient revenue and gross outpatient revenue and then dividing the resulting amount by gross inpatient revenue). The equivalent admissions computation “equates” outpatient revenue to the volume measure (admissions) used to measure inpatient volume resulting in a general measure of combined inpatient and outpatient volume. (3) Same-hospital information includes the results of the Company’s health support center and the same 70 hospitals operated during the six months ended June 30, 2017 and 2016. Same-hospital information is not applicable for the three months ended June 30, 2017 and 2016, since the results for each period are identical to the Company’s consolidated information. LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATIONDollars in millions Adjusted EBITDA is defined by the Company as earnings before depreciation and amortization; interest expense, net; other non-operating (gains) losses; provision for income taxes; and net income attributable to noncontrolling interests and redeemable noncontrolling interests. Additionally, Adjusted Normalized EBITDA excludes the impact of $24.7 million in charges related to cardiology-related lawsuits recognized during the first quarter of 2016. LifePoint’s management and Board of Directors use Adjusted EBITDA and Adjusted Normalized EBITDA to evaluate the Company’s operating performance and as a measure of performance for incentive compensation purposes. LifePoint’s credit facilities use Adjusted EBITDA, subject to further permitted adjustments, for certain financial covenants. The Company believes Adjusted EBITDA and Adjusted Normalized EBITDA are measures of performance used by some investors, equity analysts, rating agencies and lenders to make informed decisions as to, among other things, the Company’s ability to incur and service debt and make capital expenditures. In addition, multiples of current or projected Adjusted EBITDA and Adjusted Normalized EBITDA are used by some investors and equity analysts to estimate current or prospective enterprise value. Adjusted EBITDA and Adjusted Normalized EBITDA should not be considered as measures of financial performance under U.S. generally accepted accounting principles (“GAAP”), and the items excluded from Adjusted EBITDA and Adjusted Normalized EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA and Adjusted Normalized EBITDA should not be considered in isolation or as an alternative to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the condensed consolidated financial statements as an indicator of financial performance. Because Adjusted EBITDA and Adjusted Normalized EBITDA are not measurements determined in accordance with GAAP and are susceptible to varying calculations, Adjusted EBITDA and Adjusted Normalized EBITDA as presented may not be comparable to other similarly titled measures of other companies. The following table reconciles net income as reflected in the unaudited condensed consolidated statements of operations to Adjusted EBITDA and Adjusted Normalized EBITDA: % of Revenues % of Revenues % of Revenues % of Revenues LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATION (Continued)Dollars in millions The following table reconciles net income to Estimated Adjusted EBITDA as presented for the Company’s updated guidance ranges: From time to time, the Company incurs certain non-recurring gains or losses that are normally nonoperational in nature and that it does not consider relevant in assessing its ongoing operating performance. When significant, LifePoint’s management and Board of Directors typically exclude these gains or losses when evaluating the Company’s operating performance and in certain instances when evaluating performance for incentive compensation purposes. Additionally, the Company believes that some investors and equity analysts exclude these or similar items when evaluating the Company’s current or future operating performance and in making informed investment decisions regarding the Company. Accordingly, the Company provides adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders as a supplement to its comparable GAAP measure of diluted earnings per share attributable to LifePoint Health, Inc. Adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders should not be considered as a measure of financial performance under GAAP, and the items excluded from adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders are significant components in understanding and assessing financial performance. Adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders should not be considered in isolation or as an alternative to diluted earnings per share attributable to LifePoint Health, Inc. stockholders as presented in the condensed consolidated financial statements. The following table reconciles diluted earnings per share attributable to LifePoint Health, Inc. stockholders as reflected in the unaudited condensed consolidated statements of operations to adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders: Three Months Ended June 30, Six Months Ended June 30, Adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders

BRENTWOOD, Tenn.--(BUSINESS WIRE)--LifePoint Health, Inc. (NASDAQ: LPNT) today announced results for the first quarter ended March 31, 2017. For the first quarter ended March 31, 2017, consolidated revenues were $1,630.2 million, up 3.1% from $1,580.7 million for the same period last year. Net income for the first quarter ended March 31, 2017, was $64.0 million, up $40.1 million, compared with net income of $23.9 million for the same period last year. Net income for the first quarter ended March 31, 2017, includes other non-operating gains of $25.9 million, or $16.2 million net of income taxes, of which $18.0 million, or $11.3 million net of income taxes, is related to the settlement of a contingent liability previously established in connection with a prior hospital acquisition, and $7.9 million, or $4.9 million net of income taxes, is related to the transfer of certain of the Company’s home health agencies and hospices to an unconsolidated joint venture partnership. Net income for the first quarter ended March 31, 2016, includes charges of $24.7 million, or $15.5 million net of income taxes, related to cardiology-related lawsuits, and an impairment loss of $1.2 million, or $0.8 million net of income taxes, related to the write-off of certain capital assets. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the first quarter ended March 31, 2017, increased to $1.46 compared with $0.48 for the same period last year. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the first quarter ended March 31, 2017, were positively impacted by $0.39 per share as a result of the aforementioned non-operating gains in the aggregate. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the first quarter ended March 31, 2016, were negatively impacted by $0.37 per share as a result of the combination of the aforementioned cardiology-related lawsuits and impairment loss. When adjusted to exclude these various items, adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the first quarter ended March 31, 2017, increased to $1.07 per share compared with $0.85 per share for the same period last year. Additional information regarding adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders, including uses by management and others and a reconciliation to diluted earnings per share attributable to LifePoint Health, Inc. stockholders, is set forth under the section titled “Unaudited Supplemental Information.” Finally, Adjusted EBITDA for the first quarter ended March 31, 2017, increased 21.1% to $195.6 million compared with $161.6 million for the same period last year, and Adjusted Normalized EBITDA for the first quarter ended March 31, 2017, increased 5.0% to $195.6 million compared with $186.3 million for the same period last year. Adjusted Normalized EBITDA for the first quarter ended March 31, 2016, has been adjusted to exclude the impact of $24.7 million in charges related to cardiology-related lawsuits. Additional information regarding Adjusted EBITDA and Adjusted Normalized EBITDA, including definitions, uses by management and others and a reconciliation to net income, is set forth in this release under the section titled “Unaudited Supplemental Information.” Commenting on the results, William F. Carpenter III, Chairman and Chief Executive Officer of LifePoint Health, said, “We are pleased with our first quarter, in which we continued to see sequential volume improvement and margin expansion. Our efforts to integrate our recently acquired hospitals and the $2.3 billion of revenue that we have added over the last few years are on track,” said William F. Carpenter III, Chairman and Chief Executive Officer of LifePoint Health. “We remain committed to our strategic priorities of delivering high-quality care and service, growth, cost management and the development of high-performing talent to drive value for our shareholders.” A listen-only simulcast, as well as a 30-day replay, of LifePoint Health’s first quarter 2017 conference call will be available on line at www.lifepointhealth.net/investor-relations today, Friday, April 28, 2017, beginning at 10:00 a.m. Eastern Time. LifePoint Health (NASDAQ: LPNT) is a leading healthcare company dedicated to Making Communities Healthier®. Through its subsidiaries, it provides quality inpatient, outpatient and post-acute services close to home. LifePoint owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in 22 states. It is the sole community healthcare provider in the majority of the non-urban communities it serves. More information about the Company can be found at www.LifePointHealth.net. All references to “LifePoint,” “LifePoint Health” or the “Company” used in this release refer to affiliates or subsidiaries of LifePoint Health, Inc. Important Legal Information. Certain statements contained in this release are based on current management expectations and are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to qualify for the safe harbor protections from liability provided by the Private Securities Litigation Reform Act of 1995. Numerous factors exist which may cause results to differ from these expectations. Many of the factors that will determine our future results are beyond our ability to control or predict with accuracy. Such forward-looking statements reflect the current expectations and beliefs of the management of LifePoint, are not guarantees of performance and are subject to a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ from those described in the forward-looking statements. These forward-looking statements may also be subject to other risk factors and uncertainties, including without limitation: (i) the effects related to the enactment and implementation of healthcare reform, the possible repeal and replacement of the Affordable Care Act, the possible enactment of additional federal or state healthcare reforms and possible changes in healthcare reform laws and other federal, state or local laws or regulations affecting the healthcare industry including the timing of the implementation of reform; (ii) the extent to which states support increases, decreases or changes in Medicaid programs, or alter the provision of healthcare to state residents through regulation or otherwise; (iii) delays in receiving payments for services provided, reductions in Medicare or Medicaid payments (including increased recoveries made by Recovery Audit Contractors (RACs) and similar governmental agents), compared to the timing of expanded coverage; (iv) reductions in reimbursements from commercial payors and risks associated with consolidation among commercial insurance companies and shifts to insurance plans with narrow networks, high deductibles or high co-payments; (v) the continued viability of our operations through joint venture entities, the largest of which is Duke LifePoint Healthcare, our partnership with a wholly controlled affiliate of Duke University Health Systems, Inc.; (vi) our ability to successfully integrate acquired facilities into our ongoing operations and to achieve the anticipated financial results and synergies from such acquisitions, individually or in the aggregate; (vii) the deterioration in the collectability of “bad debt” and “patient due” accounts, and the number of individuals without insurance coverage (or who are underinsured) who seek care at our facilities; (viii) industry emphasis on value-based purchasing and bundled payment arrangements; (ix) whether our efforts to reduce the cost of providing healthcare while increasing the quality of care are successful; (x) the ability to attract, recruit or employ and retain qualified physicians, nurses, medical technicians and other healthcare professionals and the increasing costs associated with doing so, including the direct and indirect costs associated with employing physicians and other healthcare professionals; (xi) the loss of certain physicians in markets where such a loss can have a disproportionate impact on our facilities in such market; (xii) the application and enforcement of increasingly stringent and complex laws and regulations governing our operations and healthcare generally (and changing interpretations of applicable laws and regulations), related enforcement activity and the potentially adverse impact of known and unknown government investigations, litigation and other claims that may be made against us; (xiii) risks due to cybersecurity attack or security breach and our access to personal information of patients and employees; (xiv) our ability to successfully implement enterprise-wide information technology systems; (xv) payor controls designed to reduce inpatient services; (xvi) our ability to generate sufficient cash flow to fund all of our capital expenditure programs and commitments; (xvii) adverse events in states where a large portion of our revenues are concentrated; (xviii) liabilities resulting from potential malpractice and related legal claims brought against our facilities or the healthcare providers associated with, or employed by, such facilities or affiliated entities; (xix) our increased dependence on third parties to provide purchasing, revenue cycle and payroll services and information technology and their ability to do so effectively; (xx) our ability to acquire healthcare facilities on favorable terms and the business risks, unknown or contingent liabilities and other costs associated therewith; and (xxi) those other risks and uncertainties described from time to time in our filings with the Securities and Exchange Commission. Therefore, our future results may differ materially from those described in this release. LifePoint undertakes no obligation to update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. Less: Net income attributable to noncontrolling interests and redeemable noncontrolling interests Net income attributable to LifePoint Health, Inc. Effect of dilutive stock options and other stock-based awards Earnings per share attributable to LifePoint Health, Inc. stockholders: Accounts receivable, less allowances for doubtful accounts of $936.1 and $891.2 at March 31, 2017 and December 31, 2016, respectively Three Months EndedMarch 31, Adjustments to reconcile net income to net cash provided by operating activities: Increase (decrease) in cash from operating assets and liabilities, net of effects from acquisitions and divestitures: Interest payments LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATIONDollars in millions Adjusted EBITDA is defined by the Company as earnings before depreciation and amortization; interest expense, net; other non-operating (gains) loss; provision for income taxes; and net income attributable to noncontrolling interests and redeemable noncontrolling interests. Additionally, Adjusted Normalized EBITDA has been adjusted to exclude the impact of $24.7 million in charges related to cardiology-related lawsuits recognized during the first quarter of 2016. LifePoint’s management and Board of Directors use Adjusted EBITDA and Adjusted Normalized EBITDA to evaluate the Company’s operating performance and as a measure of performance for incentive compensation purposes. LifePoint’s credit facilities use Adjusted EBITDA, subject to further permitted adjustments, for certain financial covenants. The Company believes Adjusted EBITDA and Adjusted Normalized EBITDA are measures of performance used by some investors, equity analysts, rating agencies and lenders to make informed decisions as to, among other things, the Company’s ability to incur and service debt and make capital expenditures. In addition, multiples of current or projected Adjusted EBITDA and Adjusted Normalized EBITDA are used by some investors and equity analysts to estimate current or prospective enterprise value. Adjusted EBITDA and Adjusted Normalized EBITDA should not be considered as measures of financial performance under U.S. generally accepted accounting principles (“GAAP”), and the items excluded from Adjusted EBITDA and Adjusted Normalized EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA and Adjusted Normalized EBITDA should not be considered in isolation or as an alternative to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the condensed consolidated financial statements as an indicator of financial performance. Because Adjusted EBITDA and Adjusted Normalized EBITDA are not measurements determined in accordance with GAAP and are susceptible to varying calculations, Adjusted EBITDA and Adjusted Normalized EBITDA as presented may not be comparable to other similarly titled measures of other companies. The following table reconciles net income as reflected in the unaudited condensed consolidated statements of operations to Adjusted EBITDA and Adjusted Normalized EBITDA: Net income attributable to noncontrolling interests and redeemable noncontrolling interests LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATION (Continued)Dollars in millions From time to time, the Company incurs certain non-recurring gains or losses that are normally nonoperational in nature and that it does not consider relevant in assessing its ongoing operating performance. When significant, LifePoint’s management and Board of Directors typically exclude these gains or losses when evaluating the Company’s operating performance and in certain instances when evaluating performance for incentive compensation purposes. Additionally, the Company believes that some investors and equity analysts exclude these or similar items when evaluating the Company’s current or future operating performance and in making informed investment decisions regarding the Company. Accordingly, the Company provides adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders as a supplement to its comparable GAAP measure of diluted earnings per share attributable to LifePoint Health, Inc. Adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders should not be considered as a measure of financial performance under GAAP, and the items excluded from adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders are significant components in understanding and assessing financial performance. Adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders should not be considered in isolation or as an alternative to diluted earnings per share attributable to LifePoint Health, Inc. stockholders as presented in the condensed consolidated financial statements. The following table reconciles diluted earnings per share attributable to LifePoint Health, Inc. stockholders as reflected in the unaudited condensed consolidated statements of operations to adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders:

BRENTWOOD, Tenn.--(BUSINESS WIRE)--LifePoint Health, Inc. (NASDAQ: LPNT) today announced results for the fourth quarter and year ended December 31, 2016. For the fourth quarter ended December 31, 2016, consolidated revenues were $1,605.2 million, up 17.1% from $1,370.7 million for the same period last year, primarily as a result of the Company’s recent acquisitions. Net income for the fourth quarter ended December 31, 2016, was $46.6 million, down $8.8 million, or 16.1%, compared with net income of $55.4 million for the same period last year. Net income for the fourth quarter ended December 31, 2016, includes accelerated depreciation expense of $1.5 million, or $0.9 million net of income taxes, for the existing Marquette General Hospital because of the Company’s commitment to construct a new replacement hospital. Net income for the fourth quarter ended December 31, 2015, includes a bargain purchase gain of $4.0 million, or $2.5 million net of income taxes, related to the final valuation of an acquired hospital. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the fourth quarter ended December 31, 2016, decreased to $1.07 compared with $1.16 for the same period last year. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the fourth quarter ended December 31, 2016, were negatively impacted by $0.02 per share as a result of Marquette General Hospital accelerated depreciation expense. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the fourth quarter ended December 31, 2015, were benefited by $0.05 per share as a result of the aforementioned bargain purchase gain related to the final valuation of an acquired hospital. When adjusted to exclude these two items, adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the fourth quarter of 2016 decreased slightly to $1.09 compared with $1.11 for the same period last year, primarily as a result of an anticipated decrease in electronic health record incentive income and higher depreciation and interest expense associated with the Company’s recent acquisitions. For the year ended December 31, 2016, consolidated revenues were $6,364.0 million, up 22.0% from $5,214.3 million for the prior year, primarily as a result of the Company’s recent acquisitions. Net income for the year ended December 31, 2016, was $131.8 million, down $61.2 million, or 31.8%, compared with net income of $193.0 million for the prior year. Net income for the year ended December 31, 2016, includes charges of $24.7 million, or $15.5 million net of income taxes, related to cardiology-related lawsuits, $22.0 million, or $13.7 million net of income taxes, for debt transaction costs, $6.2 million, or $3.9 million net of income taxes, for Marquette General Hospital accelerated depreciation expense, and an impairment charge of $1.2 million, or $0.8 million net of income taxes, related to the write-off of certain capital assets. Net income for the year ended December 31, 2015, includes a bargain purchase gain of $4.0 million, or $2.5 million net of income taxes, and impairment charges of $13.8 million, or $8.9 million net of income taxes. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the year ended December 31, 2016, decreased to $2.82 compared with $3.95 for the prior year. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the year ended December 31, 2016, were negatively impacted by a total of $0.79 per share as a result of a combination of cardiology-related lawsuits, debt transaction costs, Marquette General Hospital accelerated depreciation expense, and an impairment charge. Similarly, diluted earnings per share attributable to LifePoint Health Inc. stockholders for the year ended December 31, 2015, were negatively impacted by a total of $0.14 per share as a result of impairment charges, partially offset by a bargain purchase gain. When adjusted to exclude these various items, adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders for 2016 decreased to $3.61 compared with $4.09 for the prior year, primarily as a result of an anticipated decrease in electronic health record incentive income and higher depreciation and interest expense associated with the Company’s recent acquisitions. Additional information regarding adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders, including uses by management and others and a reconciliation to diluted earnings per share attributable to LifePoint Health, Inc. stockholders, is set forth in this release under the section titled “Unaudited Supplemental Information.” Finally, Adjusted EBITDA for the fourth quarter ended December 31, 2016, increased by 6.8% to $196.8 million compared with Adjusted EBITDA of $184.2 million for the same period last year, and Adjusted Normalized EBITDA for the year ended December 31, 2016, increased 5.8% to $746.5 million compared with Adjusted Normalized EBITDA of $705.7 million for the prior year. Adjusted Normalized EBITDA for the year ended December 31, 2016, has been adjusted to exclude the impact of $24.7 million in charges related to cardiology-related lawsuits recognized during the first quarter of 2016. Additional information regarding Adjusted EBITDA and Adjusted Normalized EBITDA, including definitions, uses by management and others and a reconciliation to net income, is set forth in this release under the section titled “Unaudited Supplemental Information.” Commenting on the results, William F. Carpenter III, Chairman and Chief Executive Officer of LifePoint Health, said, “We are pleased with our fourth quarter results that contributed to a solid second half of 2016 in which we saw sequential volume improvement and margin expansion. We are well-positioned going into 2017 as our pipeline for acquisitions remains strong, and we believe the current environment may create even more opportunity as change occurs. We remain committed to focusing on quality and patient safety, as we execute on our strategic priorities and prudently allocate capital to drive value for our shareholders.” The Company also issued the following guidance for 2017: Guidance for 2017 excludes, if applicable, the estimated impact of future acquisitions, as well as the impact of items that are non-operational in nature, including items such as, but not limited to, gains or losses on early debt retirement, impairments of long-lived assets and share repurchases. This guidance is also subject to certain risks, including those as set forth in the Company’s “Important Legal Information.” A listen-only simulcast, as well as a 30-day replay, of LifePoint Health’s fourth quarter and year-end 2016 conference call will be available on line at www.lifepointhealth.net/investor-relations today, Friday, February 17, 2017, beginning at 10:00 a.m. Eastern Time. LifePoint Health (NASDAQ: LPNT) is a leading healthcare company dedicated to Making Communities Healthier®. Through its subsidiaries, it provides quality inpatient, outpatient and post-acute services close to home. LifePoint owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in 22 states. It is the sole community healthcare provider in the majority of the non-urban communities it serves. More information about the Company can be found at www.LifePointHealth.net. All references to “LifePoint,” “LifePoint Health” or the “Company” used in this release refer to affiliates or subsidiaries of LifePoint Health, Inc. Important Legal Information. Certain statements contained in this release, including LifePoint's guidance for the year ended December 31, 2017, are based on current management expectations and are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to qualify for the safe harbor protections from liability provided by the Private Securities Litigation Reform Act of 1995. Numerous factors exist which may cause results to differ from these expectations. Many of the factors that will determine our future results are beyond our ability to control or predict with accuracy. Such forward-looking statements reflect the current expectations and beliefs of the management of LifePoint, are not guarantees of performance and are subject to a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ from those described in the forward-looking statements. These forward-looking statements may also be subject to other risk factors and uncertainties, including without limitation: (i) the effects related to the enactment and implementation of healthcare reform, the possible repeal and replacement of the Affordable Care Act, the possible enactment of additional federal or state healthcare reforms and possible changes in healthcare reform laws and other federal, state or local laws or regulations affecting the healthcare industry including the timing of the implementation of reform; (ii) the extent to which states support increases, decreases or changes in Medicaid programs, or alter the provision of healthcare to state residents through regulation or otherwise; (iii) delays in receiving payments for services provided, reductions in Medicare or Medicaid payments (including increased recoveries made by Recovery Audit Contractors (RACs) and similar governmental agents), compared to the timing of expanded coverage; (iv) reductions in reimbursements from commercial payors and risks associated with consolidation among commercial insurance companies and shifts to insurance plans with narrow networks, high deductibles or high co-payments; (v) the continued viability of our operations through joint venture entities, the largest of which is Duke LifePoint Healthcare, our partnership with a wholly controlled affiliate of Duke University Health Systems, Inc.; (vi) our ability to successfully integrate acquired facilities into our ongoing operations and to achieve the anticipated financial results and synergies from such acquisitions, individually or in the aggregate; (vii) the deterioration in the collectability of “bad debt” and “patient due” accounts, and the number of individuals without insurance coverage (or who are underinsured) who seek care at our facilities; (viii) industry emphasis on value-based purchasing and bundled payment arrangements; (ix) whether our efforts to reduce the cost of providing healthcare while increasing the quality of care are successful; (x) the ability to attract, recruit or employ and retain qualified physicians, nurses, medical technicians and other healthcare professionals and the increasing costs associated with doing so, including the direct and indirect costs associated with employing physicians and other healthcare professionals; (xi) the loss of certain physicians in markets where such a loss can have a disproportionate impact on our facilities in such market; (xii) the application and enforcement of increasingly stringent and complex laws and regulations governing our operations and healthcare generally (and changing interpretations of applicable laws and regulations), related enforcement activity and the potentially adverse impact of known and unknown government investigations, litigation and other claims that may be made against us; (xiii) risks due to cybersecurity attack or security breach and our access to personal information of patients and employees; (xiv) our ability to successfully implement enterprise-wide information technology systems; (xv) payor controls designed to reduce inpatient services; (xvi) our ability to generate sufficient cash flow to fund all of our capital expenditure programs and commitments; (xvii) adverse events in states where a large portion of our revenues are concentrated; (xviii) liabilities resulting from potential malpractice and related legal claims brought against our facilities or the healthcare providers associated with, or employed by, such facilities or affiliated entities; (xix) our increased dependence on third parties to provide purchasing, revenue cycle and payroll services and information technology and their ability to do so effectively; (xx) our ability to acquire healthcare facilities on favorable terms and the business risks, unknown or contingent liabilities and other costs associated therewith; and (xxi) those other risks and uncertainties described from time to time in our filings with the Securities and Exchange Commission. Therefore, our future results may differ materially from those described in this release. LifePoint undertakes no obligation to update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. Provision for doubtful accounts Less: Net income attributable to noncontrolling interests and redeemable noncontrolling interests Net income attributable to LifePoint Health, Inc. Accounts receivable, less allowances for doubtful accounts of $891.2 and $796.8 at December 31, 2016 and 2015, respectively Adjustments to reconcile net income to net cash provided by operating activities: Increase (decrease) in cash from operating assets and liabilities, net of effects from acquisitions and divestitures: Revenues per equivalent admission Medicare case mix index Average length of stay (days) - LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATIONDollars in millions Adjusted EBITDA is defined by the Company as earnings before depreciation and amortization; interest expense, net; debt transaction costs; impairment charges; other non-operating gain; provision for income taxes; and net income attributable to noncontrolling interests and redeemable noncontrolling interests. Additionally, Adjusted Normalized EBITDA has been adjusted to exclude the impact of $24.7 million in charges related to cardiology-related lawsuits recognized during the first quarter of 2016. LifePoint’s management and Board of Directors use Adjusted EBITDA and Adjusted Normalized EBITDA to evaluate the Company’s operating performance and as a measure of performance for incentive compensation purposes. LifePoint’s credit facilities use Adjusted EBITDA, subject to further permitted adjustments, for certain financial covenants. The Company believes Adjusted EBITDA and Adjusted Normalized EBITDA are measures of performance used by some investors, equity analysts, rating agencies and lenders to make informed decisions as to, among other things, the Company’s ability to incur and service debt and make capital expenditures. In addition, multiples of current or projected Adjusted EBITDA and Adjusted Normalized EBITDA are used by some investors and equity analysts to estimate current or prospective enterprise value. Adjusted EBITDA and Adjusted Normalized EBITDA should not be considered as measures of financial performance under U.S. generally accepted accounting principles (“GAAP”), and the items excluded from Adjusted EBITDA and Adjusted Normalized EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA and Adjusted Normalized EBITDA should not be considered in isolation or as an alternative to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the condensed consolidated financial statements as an indicator of financial performance. Because Adjusted EBITDA and Adjusted Normalized EBITDA are not measurements determined in accordance with GAAP and are susceptible to varying calculations, Adjusted EBITDA and Adjusted Normalized EBITDA as presented may not be comparable to other similarly titled measures of other companies. The following table reconciles net income as reflected in the unaudited condensed consolidated statements of operations to Adjusted EBITDA and Adjusted Normalized EBITDA: LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATION (Continued)Dollars in millions From time to time, the Company incurs certain non-recurring gains or losses that are normally nonoperational in nature and that it does not consider relevant in assessing its ongoing operating performance. When significant, LifePoint’s management and Board of Directors typically exclude these gains or losses when evaluating the Company’s operating performance and in certain instances when evaluating performance for incentive compensation purposes. Additionally, the Company believes that some investors and equity analysts exclude these or similar items when evaluating the Company’s current or future operating performance and in making informed investment decisions regarding the Company. Accordingly, the Company provides adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders as a supplement to its comparable GAAP measure of diluted earnings per share attributable to LifePoint Health, Inc. Adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders should not be considered as a measure of financial performance under GAAP, and the items excluded from adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders are significant components in understanding and assessing financial performance. Adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders should not be considered in isolation or as an alternative to diluted earnings per share attributable to LifePoint Health, Inc. stockholders as presented in the condensed consolidated financial statements. The following table reconciles diluted earnings per share attributable to LifePoint Health, Inc. stockholders as reflected in the unaudited condensed consolidated statements of operations to adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders: Years Ended December 31, LifePoint Health, Inc. stockholders The following table reconciles net income to Estimated Adjusted EBITDA as presented for the Company’s 2017 guidance ranges:

BRENTWOOD, Tenn.--(BUSINESS WIRE)--LifePoint Health, Inc. (NASDAQ: LPNT) today announced results for the third quarter and nine months ended September 30, 2016. For the third quarter ended September 30, 2016, consolidated revenues were $1,585.7 million, up 21.1% from $1,309.5 million for the same period last year, primarily as a result of the Company’s recent acquisitions. Net income for the third quarter ended September 30, 2016, was $41.2 million, down $4.6 million, or 10.0%, compared with net income of $45.8 million for the same period last year. Net income for the third quarter ended September 30, 2016, includes accelerated depreciation expense of $1.5 million, or $0.9 million net of income taxes, for the existing Marquette General Hospital because of the Company’s commitment to construct a new replacement hospital. Net income for the third quarter ended September 30, 2015, includes an impairment charge of $2.2 million, or $1.4 million net of income taxes, related to the divestiture of a hospital. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the third quarter ended September 30, 2016, decreased slightly to $0.92 compared with $0.94 for the same period last year. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the third quarters ended September 30, 2016 and 2015, were negatively impacted by $0.02 per share and $0.03 per share, respectively, as a result of Marquette General Hospital accelerated depreciation expense and an impairment charge. When adjusted to exclude these two items, adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the third quarter of 2016 decreased 3.1% to $0.94 compared with $0.97 for the same period last year, primarily as a result of an anticipated decrease in electronic health record incentive income and higher depreciation and interest expense associated with the Company’s recent acquisitions. For the nine months ended September 30, 2016, consolidated revenues were $4,758.8 million, up 23.8% from $3,843.6 million for the same period last year, primarily as a result of the Company’s recent acquisitions. Net income for the nine months ended September 30, 2016, was $85.2 million, down $52.4 million, or 38.1%, compared with net income of $137.6 million for the same period last year. Net income for the nine months ended September 30, 2016, includes charges of $24.7 million, or $15.5 million net of income taxes, related to cardiology-related lawsuits, $22.0 million, or $13.7 million net of income taxes, for debt transaction costs, $4.7 million, or $2.9 million net of income taxes, for Marquette General Hospital accelerated depreciation expense, and an impairment charge of $1.2 million, or $0.8 million net of income taxes, related to the write-off of certain capital assets. Net income for the nine months ended September 30, 2015, includes impairment charges of $13.8 million, or $8.9 million net of income taxes, related to hospital divestitures. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the nine months ended September 30, 2016, decreased 36.2% to $1.78 compared with $2.79 for the same period last year. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the nine months ended September 30, 2016, were negatively impacted by a total of $0.75 per share as a result of a combination of cardiology-related lawsuits, debt transaction costs, Marquette General Hospital accelerated depreciation expense, and an impairment charge. Similarly, diluted earnings per share attributable to LifePoint Health Inc. stockholders for the nine months ended September 30, 2015, were negatively impacted by a total of $0.19 per share as a result of impairment charges. When adjusted to exclude these various items, adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the first nine months of 2016 decreased 15.1% to $2.53 compared with $2.98 for the same period last year, primarily as a result of an anticipated decrease in electronic health record incentive income and higher depreciation and interest expense associated with the Company’s recent acquisitions. Additional information regarding adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders, including uses by management and others and a reconciliation to diluted earnings per share attributable to LifePoint Health, Inc. stockholders, is set forth in this release under the section titled “Unaudited Supplemental Information.” Finally, Adjusted EBITDA for the third quarter ended September 30, 2016, increased by 8.9% to $188.0 million compared with Adjusted EBITDA of $172.7 million for the same period last year, and Adjusted Normalized EBITDA for the nine months ended September 30, 2016, increased 5.4% to $549.7 million compared with Adjusted Normalized EBITDA of $521.5 million for the same period last year. Adjusted Normalized EBITDA for the nine months ended September 30, 2016, has been adjusted to exclude the impact of $24.7 million in charges related to cardiology-related lawsuits recognized during the first quarter of 2016. Additional information regarding Adjusted EBITDA and Adjusted Normalized EBITDA, including definitions, uses by management and others and a reconciliation to net income, is set forth in this release under the section titled “Unaudited Supplemental Information.” “We are pleased with our results for the quarter,” said William F. Carpenter III, Chairman and Chief Executive Officer of LifePoint Health. “We are disciplined operators, and our core business is solid and performing well. In the quarter, we generated strong cash flows and drove sequential improvement in our same-hospital margins when excluding the impact of meaningful use. This quarter, we were active buyers of LifePoint shares, and we will continue to allocate capital to drive the greatest long-term value for our shareholders. In addition, our acquisition pipeline remains strong, and we remain the partner of choice for many hospitals and health systems across the country.” A listen-only simulcast, as well as a 30-day replay, of LifePoint Health’s third quarter 2016 conference call will be available on line at www.lifepointhealth.net/investor-relations today, Friday, October 28, 2016, beginning at 10:00 a.m. Eastern Time. LifePoint Health (NASDAQ: LPNT) is a leading healthcare company dedicated to Making Communities Healthier®. Through its subsidiaries, it provides quality inpatient, outpatient and post-acute services close to home. LifePoint owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in 22 states. It is the sole community healthcare provider in the majority of the non-urban communities it serves. More information about the Company can be found at www.LifePointHealth.net. All references to “LifePoint,” “LifePoint Health” or the “Company” used in this release refer to affiliates or subsidiaries of LifePoint Health, Inc. Important Legal Information. Certain statements contained in this release are based on current management expectations and are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to qualify for the safe harbor protections from liability provided by the Private Securities Litigation Reform Act of 1995. Numerous factors exist which may cause results to differ from these expectations. Many of the factors that will determine our future results are beyond our ability to control or predict with accuracy. Such forward-looking statements reflect the current expectations and beliefs of the management of LifePoint, are not guarantees of performance and are subject to a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ from those described in the forward-looking statements. These forward-looking statements may also be subject to other risk factors and uncertainties, including without limitation: (i) the effects related to the enactment and implementation of healthcare reform, the possible enactment of additional federal or state healthcare reforms and possible changes in healthcare reform laws and other federal, state or local laws or regulations affecting the healthcare industry including the timing of the implementation of reform; (ii) the extent to which states support increases, decreases or changes in Medicaid programs, or alter the provision of healthcare to state residents through regulation or otherwise; (iii) delays in receiving payments for services provided, reductions in Medicare or Medicaid payments (including increased recoveries made by Recovery Audit Contractors (RACs) and similar governmental agents), compared to the timing of expanded coverage; (iv) reductions in reimbursements from commercial payors; (v) our ability to acquire healthcare facilities on favorable terms and the business risks, unknown or contingent liabilities and other costs associated therewith; (vi) our ability to successfully integrate acquired facilities into our ongoing operations and to achieve the anticipated financial results and synergies from such acquisitions, individually or in the aggregate; (vii) our ongoing ability to demonstrate meaningful use of certified electronic health record technology and recognize income for the related Medicare or Medicaid incentive payments; (viii) the deterioration in the collectability of “bad debt” and “patient due” accounts, and the number of individuals without insurance coverage (or who are underinsured) who seek care at our facilities; (ix) whether our core strategies will result in anticipated operating results, including measurable quality and satisfaction improvements; (x) whether our efforts to reduce the cost of providing healthcare while increasing the quality of care are successful; (xi) the ability to attract, recruit or employ and retain qualified physicians, nurses, medical technicians and other healthcare professionals and the increasing costs associated with doing so, including the direct and indirect costs associated with employing physicians and other healthcare professionals; (xii) the loss of certain physicians in markets where such a loss can have a disproportionate impact on our facilities in such market; (xiii) the application and enforcement of increasingly stringent and complex laws and regulations governing our operations and healthcare generally (and changing interpretations of applicable laws and regulations), related enforcement activity and the potentially adverse impact of known and unknown government investigations, litigation and other claims that may be made against us; (xiv) any interruption of or restriction in our prompt access to licensed or owned information (and information technology systems) or failure in our ability to integrate changes to our existing information systems or information systems of acquired facilities; (xv) adverse events in states where a large portion of our revenues are concentrated; (xvi) liabilities resulting from potential malpractice and related legal claims brought against our facilities or the healthcare providers associated with, or employed by, such facilities or affiliated entities; (xvii) our increased dependence on third parties to provide purchasing, revenue cycle and payroll services and information technology and their ability to do so effectively; (xviii) the continued viability of our operations through joint venture entities, the largest of which is Duke LifePoint Healthcare, our partnership with a wholly controlled affiliate of Duke University Health Systems, Inc.; and (xix) those other risks and uncertainties described from time to time in our filings with the Securities and Exchange Commission. Therefore, our future results may differ materially from those described in this release. LifePoint undertakes no obligation to update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. LIFEPOINT HEALTH, INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Dollars in millions, except per share amounts September 30, September 30, % ofRevenues % ofRevenues % ofRevenues % ofRevenues Revenues before provision for doubtful accounts Depreciation and amortization LIFEPOINT HEALTH, INC. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS Dollars in millions 2016 2015 Accounts receivable, less allowances for doubtful accounts of $874.6 and $796.8 at September 30, 2016, and December 31, 2015, respectively LIFEPOINT HEALTH, INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Dollars in millions Adjustments to reconcile net income to net cash provided by operating activities: net of effects from acquisitions and divestitures: LIFEPOINT HEALTH, INC. UNAUDITED STATISTICS September 30, September 30, %Change %Change - LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATIONDollars in millions Adjusted EBITDA is defined by the Company as earnings before depreciation and amortization; interest expense, net; debt transaction costs; impairment charges; provision for income taxes; and net income attributable to noncontrolling interests and redeemable noncontrolling interests. Additionally, Adjusted Normalized EBITDA has been adjusted to exclude the impact of $24.7 million in charges related to cardiology-related lawsuits recognized during the first quarter of 2016. LifePoint’s management and Board of Directors use Adjusted EBITDA and Adjusted Normalized EBITDA to evaluate the Company’s operating performance and as a measure of performance for incentive compensation purposes. LifePoint’s credit facilities use Adjusted EBITDA, subject to further permitted adjustments, for certain financial covenants. The Company believes Adjusted EBITDA and Adjusted Normalized EBITDA are measures of performance used by some investors, equity analysts, rating agencies and lenders to make informed decisions as to, among other things, the Company’s ability to incur and service debt and make capital expenditures. In addition, multiples of current or projected Adjusted EBITDA and Adjusted Normalized EBITDA are used by some investors and equity analysts to estimate current or prospective enterprise value. Adjusted EBITDA and Adjusted Normalized EBITDA should not be considered as measures of financial performance under U.S. generally accepted accounting principles (“GAAP”), and the items excluded from Adjusted EBITDA and Adjusted Normalized EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA and Adjusted Normalized EBITDA should not be considered in isolation or as an alternative to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the condensed consolidated financial statements as an indicator of financial performance. Because Adjusted EBITDA and Adjusted Normalized EBITDA are not measurements determined in accordance with GAAP and are susceptible to varying calculations, Adjusted EBITDA and Adjusted Normalized EBITDA as presented may not be comparable to other similarly titled measures of other companies. The following table reconciles net income as reflected in the unaudited condensed consolidated statements of operations to Adjusted EBITDA and Adjusted Normalized EBITDA: % ofRevenues % ofRevenues % ofRevenues % ofRevenues - - - LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATION (Continued)Dollars in millions From time to time, the Company incurs certain non-recurring gains or losses that are normally nonoperational in nature and that it does not consider relevant in assessing its ongoing operating performance. When significant, LifePoint’s management and Board of Directors typically exclude these gains or losses when evaluating the Company’s operating performance and in certain instances when evaluating performance for incentive compensation purposes. Additionally, the Company believes that some investors and equity analysts exclude these or similar items when evaluating the Company’s current or future operating performance and in making informed investment decisions regarding the Company. Accordingly, the Company provides adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders as a supplement to its comparable GAAP measure of diluted earnings per share attributable to LifePoint Health, Inc. Adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders should not be considered as a measure of financial performance under GAAP, and the items excluded from adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders are significant components in understanding and assessing financial performance. Adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders should not be considered in isolation or as an alternative to diluted earnings per share attributable to LifePoint Health, Inc. stockholders as presented in the condensed consolidated financial statements. The following table reconciles diluted earnings per share attributable to LifePoint Health, Inc. stockholders as reflected in the unaudited condensed consolidated statements of operations to adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders: Adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders

BRENTWOOD, Tenn.--(BUSINESS WIRE)--LifePoint Health, Inc. (NASDAQ: LPNT) today announced results for the second quarter and six months ended June 30, 2016. For the second quarter ended June 30, 2016, consolidated revenues were $1,592.4 million, up 25.3% from $1,270.4 million for the same period last year, primarily as a result of our recent acquisitions in Flemingsburg, Kentucky, Jeffersonville, Indiana, Watertown, Wisconsin, Hickory, North Carolina, Sanford, North Carolina, Columbus, Georgia and Columbia, South Carolina. Net income for the second quarter ended June 30, 2016, was $20.1 million, down $29.7 million, or 59.6%, compared with net income of $49.8 million for the same period last year. Net income for the second quarter ended June 30, 2016, includes charges of $22.0 million, or $13.7 million net of income taxes, for debt transaction costs related to the extinguishment of certain existing debt instruments and the issuance of certain new debt instruments as well as accelerated depreciation expense of $1.5 million, or $0.9 million net of income taxes, for the existing Marquette General Hospital because of our commitment to construct a new replacement hospital. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the second quarter ended June 30, 2016, decreased 62.0% to $0.38 compared with $1.00 for the same period last year. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the second quarter ended June 30, 2016, was negatively impacted by a total of $0.33 per share as a result of a combination of debt transaction costs and Marquette General Hospital accelerated depreciation expense. When adjusted to exclude these two items, adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the second quarter of 2016 decreased 29.0% to $0.71 compared with $1.00 for the same period last year, primarily as a result of higher depreciation, amortization, and interest expense associated with our recent acquisitions. For the six months ended June 30, 2016, consolidated revenues were $3,173.1 million, up 25.2% from $2,534.1 million for the same period last year, primarily as a result of the aforementioned recent acquisitions as well as the acquisition of a hospital in Roaring Spring, Pennsylvania. Net income for the first half of 2016 was $44.0 million, down $47.8 million, or 52.1%, compared with net income of $91.8 million for the same period last year. Net income for the six months ended June 30, 2016, includes charges of $22.0 million, or $13.7 million net of income taxes, for debt transaction costs, $3.2 million, or $2.0 million net of income taxes, attributable to Marquette General Hospital accelerated depreciation expense, charges of $24.7 million, or $15.5 million net of income taxes, related to cardiology-related lawsuits and a $1.2 million impairment charge, or $0.8 million net of income taxes, related to the write-off of certain capital assets. Similarly, net income for the six months ended June 30, 2015, includes impairment charges of $11.6 million, or $7.5 million net of income taxes, related to the strategic divestitures of four hospitals. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the six months ended June 30, 2016, decreased 52.7% to $0.87 compared with $1.84 for the same period last year. Diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the six months ended June 30, 2016, was negatively impacted by a total of $0.72 per share as a result of a combination of debt transaction costs, Marquette General Hospital accelerated depreciation expense, cardiology-related lawsuits and an impairment charge. Similarly, diluted earnings per share attributable to LifePoint Health Inc. stockholders for the six months ended June 30, 2015, was negatively impacted by a total of $0.16 per share as a result of impairment charges. When adjusted to exclude these various items, adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the first half of 2016 decreased 20.5% to $1.59 compared with $2.00 for the same period last year, primarily as a result of higher depreciation, amortization, and interest expense associated with our recent acquisitions. Finally, Adjusted EBITDA for the second quarter ended June 30, 2016, increased slightly by 0.2% to $175.4 million compared with Adjusted EBITDA of $175.0 million for the same period last year and Adjusted Normalized EBITDA for the six months ended June 30, 2016, increased 3.7% to $361.7 million compared with Adjusted Normalized EBITDA of $348.8 million for the same period last year. Adjusted Normalized EBITDA for the six months ended June 30, 2016, has been adjusted to exclude the impact of $24.7 million in charges related to cardiology-related lawsuits recognized during the first quarter of 2016. Additional information regarding Adjusted EBITDA and Adjusted Normalized EBITDA, including definitions, uses by management and others and a reconciliation to net income, is set forth in this release under the section titled “Unaudited Supplemental Information.” “We remain focused on executing on our strategic plan and driving shareholder value,” said William F. Carpenter III, Chairman and Chief Executive Officer of LifePoint Health. “While we did not meet our expectations, the shortfall was isolated primarily to two hospitals, where we took proactive steps that position us to achieve our long-term quality and financial goals. Our business remains strong, and we are confident we will deliver on our revised guidance in the second half.” In the quarter, one of the Company’s largest hospitals experienced the loss of certain key physicians, including the Company’s decision to part ways with the physician leader of a key service line. This resulted in additional professional fees, call pay, severance costs and recruiting expenses. At a recently acquired hospital, the Company chose to incur additional expense to implement a new physician billing system to ensure accuracy and to help achieve long-term synergies. The Company estimates the collective impact of these expenses in the quarter to be approximately $15.0 million. Our cash flows provided by operating activities for the three and six months ended June 30, 2016, as compared to the same periods last year were negatively impacted by the timing of payments for income taxes and interest as well as a decrease in the amount and timing of receipts related to certain Medicaid disproportionate share hospital programs and outstanding accounts receivable. The timing of cash collections for outstanding accounts receivable was negatively impacted as a result of the time lag involved in obtaining the necessary authorizations to begin billing under the Medicare, Medicaid and other private insurers programs at certain of our recently acquired facilities. We obtained all of the required approvals during the second quarter of 2016. The Company’s revised guidance for 2016 is: $3.43 - $3.70 Guidance excludes the impact of $24.7 million in charges for cardiology-related lawsuits recognized in the first half of 2016 as well as the first half or future impact of items that are non-operational in nature, including items such as, but not limited to, debt transaction costs, Marquette General Hospital accelerated depreciation, changes in depreciation and amortization expense for recent acquisitions as a result of the finalization of the valuations of certain tangible and intangible assets acquired, impairment charges and share repurchases, if any. Additionally, guidance excludes the estimated impact of future acquisitions, if applicable. Finally, this guidance is subject to certain risks including those as set forth in the Company’s “Important Legal Information.” A listen-only simulcast, as well as a 30-day replay, of LifePoint Health’s second quarter 2016 conference call will be available on line at www.lifepointhealth.net/investor-relations today, Friday, July 29, 2016, beginning at 10:00 a.m. Eastern Time. LifePoint Health (NASDAQ: LPNT) is a leading healthcare company dedicated to Making Communities Healthier®. Through its subsidiaries, it provides quality inpatient, outpatient and post-acute services close to home. LifePoint owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in 22 states. It is the sole community healthcare provider in the majority of the non-urban communities it serves. More information about the Company can be found at www.LifePointHealth.net. All references to “LifePoint,” “LifePoint Health” or the “Company” used in this release refer to affiliates or subsidiaries of LifePoint Health, Inc. Important Legal Information. Certain statements contained in this release, including LifePoint’s revised Guidance for the year ended December 31, 2016, are based on current management expectations and are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to qualify for the safe harbor protections from liability provided by the Private Securities Litigation Reform Act of 1995. Numerous factors exist which may cause results to differ from these expectations. Many of the factors that will determine our future results are beyond our ability to control or predict with accuracy. Such forward-looking statements reflect the current expectations and beliefs of the management of LifePoint, are not guarantees of performance and are subject to a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ from those described in the forward-looking statements. These forward-looking statements may also be subject to other risk factors and uncertainties, including without limitation: (i) the effects related to the enactment and implementation of healthcare reform, the possible enactment of additional federal or state healthcare reforms and possible changes in healthcare reform laws and other federal, state or local laws or regulations affecting the healthcare industry including the timing of the implementation of reform; (ii) the extent to which states support increases, decreases or changes in Medicaid programs, or alter the provision of healthcare to state residents through regulation or otherwise; (iii) delays in receiving payments for services provided, reductions in Medicare or Medicaid payments (including increased recoveries made by Recovery Audit Contractors (RACs) and similar governmental agents), compared to the timing of expanded coverage; (iv) reductions in reimbursements from commercial payors; (v) our ability to acquire healthcare facilities on favorable terms and the business risks, unknown or contingent liabilities and other costs associated therewith; (vi) our ability to successfully integrate acquired facilities into our ongoing operations and to achieve the anticipated financial results and synergies from such acquisitions, individually or in the aggregate; (vii) our ongoing ability to demonstrate meaningful use of certified electronic health record technology and recognize income for the related Medicare or Medicaid incentive payments; (viii) the deterioration in the collectability of “bad debt” and “patient due” accounts, and the number of individuals without insurance coverage (or who are underinsured) who seek care at our facilities; (ix) whether our core strategies will result in anticipated operating results, including measurable quality and satisfaction improvements; (x) whether our efforts to reduce the cost of providing healthcare while increasing the quality of care are successful; (xi) the ability to attract, recruit or employ and retain qualified physicians, nurses, medical technicians and other healthcare professionals and the increasing costs associated with doing so, including the direct and indirect costs associated with employing physicians and other healthcare professionals; (xii) the loss of certain physicians in markets where such a loss can have a disproportionate impact on our facilities in such market; (xiii) the application and enforcement of increasingly stringent and complex laws and regulations governing our operations and healthcare generally (and changing interpretations of applicable laws and regulations), related enforcement activity and the potentially adverse impact of known and unknown government investigations, litigation and other claims that may be made against us; (xiv) any interruption of or restriction in our prompt access to licensed or owned information (and information technology systems) or failure in our ability to integrate changes to our existing information systems or information systems of acquired facilities; (xv) adverse events in states where a large portion of our revenues are concentrated; (xvi) liabilities resulting from potential malpractice and related legal claims brought against our facilities or the healthcare providers associated with, or employed by, such facilities or affiliated entities; (xvii) our increased dependence on third parties to provide purchasing, revenue cycle and payroll services and information technology and their ability to do so effectively; (xviii) the continued viability of our operations through joint venture entities, the largest of which is Duke LifePoint Healthcare, our partnership with a wholly controlled affiliate of Duke University Health Systems, Inc.; and (xix) those other risks and uncertainties described from time to time in our filings with the Securities and Exchange Commission. Therefore, our future results may differ materially from those described in this release. LifePoint undertakes no obligation to update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. Revenues before provision for doubtful accounts Provision for doubtful accounts - Accounts receivable, less allowances for doubtful accounts of $854.8 and $796.8 at June 30, 2016, and December 31, 2015, respectively Noncontrolling interests Adjustments to reconcile net income to net cash provided by operating activities: Increase (decrease) in cash from operating assets and liabilities, net of effects from acquisitions and divestitures: Net cash used in investing activities Net cash provided by (used in) financing activities - (1) Consolidated information includes the results of our health support center, our same-hospital operations and the results of our recent acquisitions. Additionally, consolidated information includes the results of our hospitals that have previously been disposed. (2) Management and investors use equivalent admissions as a general measure of combined inpatient and outpatient volume. We compute equivalent admissions by multiplying admissions (inpatient volumes) by the outpatient factor (the sum of gross inpatient revenue and gross outpatient revenue and then dividing the resulting amount by gross inpatient revenue). The equivalent admissions computation “equates” outpatient revenue to the volume measure (admissions) used to measure inpatient volume resulting in a general measure of combined inpatient and outpatient volume. (3) Same-hospital information includes the results of our health support center and the same 64 hospitals operated during the three months ended June 30, 2016 and 2015, and the same 63 hospitals operated during the six months ended June 30, 2016 and 2015. Same-hospital information excludes our hospitals that have previously been disposed. LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATIONDollars in millions Adjusted EBITDA is defined by the Company as earnings before depreciation and amortization; interest expense, net; debt transaction costs; impairment charges; provision for income taxes; and net income attributable to noncontrolling interests and redeemable noncontrolling interests. Additionally, Adjusted Normalized EBITDA has been adjusted to exclude the impact of $24.7 million in charges related to cardiology-related lawsuits recognized during the first quarter of 2016. LifePoint’s management and Board of Directors use Adjusted EBITDA and Adjusted Normalized EBITDA to evaluate the Company’s operating performance and as a measure of performance for incentive compensation purposes. LifePoint’s credit facilities use Adjusted EBITDA, subject to further permitted adjustments, for certain financial covenants. The Company believes Adjusted EBITDA and Adjusted Normalized EBITDA are measures of performance used by some investors, equity analysts, rating agencies and lenders to make informed decisions as to, among other things, our ability to incur and service debt and make capital expenditures. In addition, multiples of current or projected Adjusted EBITDA and Adjusted Normalized EBITDA are used by some investors and equity analysts to estimate current or prospective enterprise value. Adjusted EBITDA and Adjusted Normalized EBITDA should not be considered as measures of financial performance under U.S. generally accepted accounting principles (“GAAP”), and the items excluded from Adjusted EBITDA and Adjusted Normalized EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA and Adjusted Normalized EBITDA should not be considered in isolation or as an alternative to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the condensed consolidated financial statements as an indicator of financial performance. Because Adjusted EBITDA and Adjusted Normalized EBITDA are not measurements determined in accordance with GAAP and are susceptible to varying calculations, Adjusted EBITDA and Adjusted Normalized EBITDA as presented may not be comparable to other similarly titled measures of other companies. The following table reconciles net income as reflected in the unaudited condensed consolidated statements of operations to Adjusted EBITDA and Adjusted Normalized EBITDA: Less: Net income attributable to noncontrolling interests and redeemable noncontrolling interests Net income attributable to LifePoint Health, Inc. - Net income attributable to noncontrolling interests and redeemable noncontrolling interests LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATION (Continued)Dollars in millions The following table reconciles net income to Adjusted Normalized EBITDA as presented for the Company’s updated guidance ranges: From time to time, the Company incurs certain non-recurring gains or losses that are normally nonoperational in nature and that it does not consider relevant in assessing its ongoing operating performance. When significant, LifePoint’s management and Board of Directors typically exclude these gains or losses when evaluating the Company’s operating performance and in certain instances when evaluating performance for incentive compensation purposes. Additionally, the Company believes that some investors and equity analysts exclude these or similar items when evaluating the Company’s current or future operating performance and in making informed investment decisions regarding the Company. Accordingly, the Company provides adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders as a supplement to its comparable GAAP measure of diluted earnings per share attributable to LifePoint Health, Inc. Adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders should not be considered as a measure of financial performance under GAAP, and the items excluded from adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders are significant components in understanding and assessing financial performance. Adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders should not be considered in isolation or as an alternative to diluted earnings per share attributable to LifePoint Health, Inc. stockholders as presented in the condensed consolidated financial statements. The following table reconciles diluted earnings per share attributable to LifePoint Health, Inc. stockholders as reflected in the unaudited condensed consolidated statements of operations to adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders: LifePoint Health, Inc. stockholders LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATION (Continued)Dollars in millions The following table reconciles diluted earnings per share attributable to LifePoint Health, Inc. stockholders to adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders, as presented for the Company’s updated guidance ranges:

BRENTWOOD, Tenn.--(BUSINESS WIRE)--LifePoint Health, Inc. (NASDAQ: LPNT) today announced results for the first quarter ended March 31, 2016. For the first quarter ended March 31, 2016, consolidated revenues were $1,580.7 million, up 25.1% from $1,263.7 million for the same period last year. Excluding certain items that adversely affected the Company’s financial performance for the three months ended March 31, 2016 and 2015, and as discussed in more detail below, the Company’s Adjusted Normalized EBITDA for the first quarter ended March 31, 2016, increased 7.2% to $186.3 million compared with Adjusted EBITDA of $173.8 million for the same period last year. Adjusted diluted earnings per share attributable to LifePoint Health, Inc. stockholders for the first quarter ended March 31, 2016, decreased 13.0% to $0.87 compared with $1.00 for the same period last year as a result of improved operating results, offset by higher depreciation and amortization expense associated with its recent acquisitions and greater interest expense. “We are pleased with our first quarter performance, which demonstrates the strength of our strategic plan and our ability to deliver solid operational results,” said William F. Carpenter III, Chairman and Chief Executive Officer of LifePoint Health. “When adjusted for certain one-time items, our financial performance was in line with our expectations. We remain focused on our strategic priorities of delivering high quality patient care, growing organically and through strategic acquisitions, managing costs and developing high performing talent. This focus, as well as our strong balance sheet, has and will continue to drive value for our shareholders.” The Company provides the following tables and explanations for certain items that adversely affected the Company’s financial performance for the three months ended March 31, 2016 and 2015: Three Months EndedMarch 31, 2016 % ofRevenues Three Months EndedMarch 31, Earnings per share attributable to LifePoint Health, Inc. stockholders – Diluted Earnings per share attributable to LifePoint Health, Inc. stockholders – Adjusted Diluted The Company has previously disclosed lawsuits related to interventional cardiology procedures. The Company accrues an estimate for a contingent liability when losses are both probable and reasonably estimable. Additionally, the Company reviews its accruals each quarter and adjusts them to reflect the impact of developments, advice of legal counsel and other information pertaining to a particular matter. At March 31, 2016, the Company has recorded an accrual for loss contingencies for cardiology-related lawsuits of $41.9 million. This accrual is partially offset by an estimated insurance coverage receivable of $17.2 million and resulted in a net period expense of $24.7 million, or $0.35 loss per diluted share, during the three months ended March 31, 2016. During the three months ended March 31, 2016, the Company recognized an impairment charge of $1.2 million, or $0.02 loss per diluted share, related to the write-off of certain capital assets that it has determined are no longer a necessary component of its ongoing information technology strategy. Additionally, during the three months ended March 31, 2015, the Company recognized impairment charges totaling $11.6 million, or $0.16 loss per diluted share, related to the strategic divestitures of four hospitals. Finally, during the three months ended March 31, 2016, the Company recognized additional accelerated depreciation expense of $1.7 million, or $0.02 loss per diluted share, for the existing Marquette General Hospital as a result of its commitment to construct a replacement hospital. The additional depreciation expense will reduce the carrying value of the existing hospital campus down to its estimated fair value at the end of the projected construction period for the replacement hospital. The Company currently estimates this acceleration will result in approximately $6.0 million of additional depreciation expense over each of the next three years. This estimate is subject to change as a result of possible modifications to the Company’s plans for the existing hospital. A listen-only simulcast, as well as a 30-day replay, of LifePoint Health’s first quarter 2016 conference call will be available on line at www.lifepointhealth.net/investor-relations today, Friday, April 29, 2016, beginning at 10:00 a.m. Eastern Time. LifePoint Health (NASDAQ: LPNT) is a leading healthcare company dedicated to Making Communities Healthier®. Through its subsidiaries, it provides quality inpatient, outpatient and post-acute services close to home. LifePoint owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in 22 states. It is the sole community healthcare provider in the majority of the non-urban communities it serves. More information about the Company can be found at www.LifePointHealth.net. All references to “LifePoint,” “LifePoint Health” or the “Company” used in this release refer to affiliates or subsidiaries of LifePoint Health, Inc. Important Legal Information. Certain statements contained in this release are based on current management expectations and are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to qualify for the safe harbor protections from liability provided by the Private Securities Litigation Reform Act of 1995. Numerous factors exist which may cause results to differ from these expectations. Many of the factors that will determine our future results are beyond our ability to control or predict with accuracy. Such forward-looking statements reflect the current expectations and beliefs of the management of LifePoint, are not guarantees of performance and are subject to a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ from those described in the forward-looking statements. These forward-looking statements may also be subject to other risk factors and uncertainties, including without limitation: (i) the effects related to the enactment and implementation of healthcare reform, the possible enactment of additional federal or state healthcare reforms and possible changes in healthcare reform laws and other federal, state or local laws or regulations affecting the healthcare industry including the timing of the implementation of reform; (ii) the extent to which states support increases, decreases or changes in Medicaid programs, implement healthcare exchanges or alter the provision of healthcare to state residents through regulation or otherwise; (iii) delays in receiving payments for services provided, reductions in Medicare or Medicaid payments (including increased recoveries made by Recovery Audit Contractors (RAC) and similar governmental agents), compared to the timing of expanded coverage; (iv) reductions in reimbursements from commercial payors; (v) our ability to acquire healthcare facilities on favorable terms and the business risks, unknown or contingent liabilities and other costs associated therewith; (vi) our ability to successfully integrate acquired facilities into our ongoing operations and to achieve the anticipated financial results and synergies from such acquisitions, individually or in the aggregate; (vii) our ongoing ability to demonstrate meaningful use of certified electronic health record technology and recognize income for the related Medicare or Medicaid incentive payments; (viii) the deterioration in the collectability of “bad debt” and “patient due” accounts, the number of individuals without insurance coverage (or who are underinsured) who seek care at our facilities; (ix) whether our core strategies will result in anticipated operating results, including measurable quality and satisfaction improvements; (x) whether our efforts to reduce the cost of providing healthcare while increasing the quality of care are successful; (xi) the ability to attract, recruit or employ and retain qualified physicians, nurses, medical technicians and other healthcare professionals and the increasing costs associated with doing so, including the direct and indirect costs associated with employing physicians and other healthcare professionals; (xii) the loss of certain physicians in markets where such a loss can have a disproportionate impact on our facilities in such market; (xiii) the application, interpretation and enforcement of increasingly stringent and complex laws and regulations governing our operations and healthcare generally (and changing interpretations of applicable laws and regulations), related enforcement activity and the potentially adverse impact of known and unknown government investigations, litigation and other claims that may be made against us; (xiv) any interruption of or restriction in our prompt access to licensed or owned information (and information technology systems) or failure in our ability to integrate changes to LifePoint’s existing information systems or information systems of acquired facilities; (xv) adverse events in states where a large portion of our revenues are concentrated; (xvi) liabilities resulting from potential malpractice and related legal claims brought against our facilities or the healthcare providers associated with, or employed by, such facilities or affiliated entities; (xvii) our increased dependence on third parties to provide purchasing, revenue cycle and payroll services and information technology and whether they are able to do so effectively; (xviii) the continued viability of our operations through joint venture entities, the largest of which is Duke LifePoint Healthcare, our partnership with a wholly controlled affiliate of Duke University Health Systems, Inc.; and (xix) those other risks and uncertainties described from time to time in our filings with the Securities and Exchange Commission. Therefore, our future results may differ materially from those described in this release. LifePoint undertakes no obligation to update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. LIFEPOINT HEALTH, INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Dollars in millions, except per share amounts % ofRevenues % ofRevenues Less: Net income attributable to noncontrolling interests and redeemable noncontrolling interests Earnings per share attributable to LifePoint Health, Inc. stockholders: LIFEPOINT HEALTH, INC. UNAUDITED EARNINGS PER SHARE CALCULATIONS In millions, except per share amounts Three Months EndedMarch 31, Less: Net income attributable to noncontrolling interests and redeemable noncontrolling interests LIFEPOINT HEALTH, INC. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS Dollars in millions March 31,2016 Dec. 31,2015 Accounts receivable, less allowances for doubtful accounts of $833.4 and $796.8 at March 31, 2016, and December 31, 2015, respectively LIFEPOINT HEALTH, INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Dollars in millions Adjustments to reconcile net income to net cash provided by operating activities: Increase (decrease) in cash from operating assets and liabilities, net of effects from acquisitions and divestitures: LIFEPOINT HEALTH, INC. UNAUDITED STATISTICS March 31, %Change LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATIONDollars in millions Adjusted EBITDA is defined by the Company as earnings before depreciation and amortization; interest expense, net; impairment charges; provision for income taxes; and net income attributable to noncontrolling interests and redeemable noncontrolling interests. LifePoint’s management and Board of Directors use Adjusted EBITDA to evaluate the Company’s operating performance and as a measure of performance for incentive compensation purposes. LifePoint’s credit facilities use Adjusted EBITDA, subject to further permitted adjustments, for certain financial covenants. The Company believes Adjusted EBITDA is a measure of performance used by some investors, equity analysts and others to make informed investment decisions. In addition, multiples of current or projected Adjusted EBITDA are used to estimate current or prospective enterprise value. Adjusted EBITDA should not be considered as a measure of financial performance under U.S. generally accepted accounting principles (“GAAP”), and the items excluded from Adjusted EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA should not be considered in isolation or as an alternative to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the condensed consolidated financial statements as an indicator of financial performance or liquidity. Because Adjusted EBITDA is not a measurement determined in accordance with GAAP and is susceptible to varying calculations, Adjusted EBITDA as presented may not be comparable to other similarly titled measures of other companies. % ofRevenues % ofRevenues The following table reconciles Adjusted EBITDA as presented above to net income attributable to LifePoint Health, Inc. as reflected in the unaudited condensed consolidated statements of operations: Three Months EndedMarch 31, Net income attributable to noncontrolling interests and redeemable noncontrolling interests

BRENTWOOD, Tenn.--(BUSINESS WIRE)--LifePoint Health, Inc. (NASDAQ: LPNT) today announced results for the fourth quarter and year ended December 31, 2015. For the fourth quarter ended December 31, 2015, consolidated revenues were $1,370.7 million, up 8.5% from $1,262.9 million for the same period last year. Adjusted EBITDA for the fourth quarter ended December 31, 2015, increased 5.9% to $184.2 million compared with $174.0 million for the same period last year. Adjusted EBITDA for the fourth quarter ended December 31, 2015, excludes a bargain purchase gain of $4.0 million, or $0.05 per diluted share, related to the final valuation of a recently acquired hospital. Adjusted EBITDA for the fourth quarter ended December 31, 2014, excludes impairment charges of $45.5 million, or $0.60 per diluted share, for the write down of property, equipment, allocated goodwill and certain other assets in connection with the sale of three hospitals in Alabama. Net income attributable to LifePoint Health, Inc. stockholders for the fourth quarter ended December 31, 2015, increased 136.9% to $53.0 million, or $1.16 per diluted share, compared with $22.4 million, or $0.48 per diluted share, for the same period last year. When adjusted to exclude the bargain purchase gain and impairment charges discussed above, diluted earnings per share for the fourth quarters ended December 31, 2015 and 2014, were $1.11 and $1.08, respectively. For the year ended December 31, 2015, consolidated revenues were $5,214.3 million, up 16.3% from $4,483.1 million for the prior year. Adjusted EBITDA for the year ended December 31, 2015, increased 11.3% to $705.7 million compared with $634.2 million for the prior year. Adjusted EBITDA for the year ended December 31, 2015, excludes a bargain purchase gain of $4.0 million, or $0.05 per diluted share, and impairment charges of $13.8 million, or $0.19 per diluted share. Adjusted EBITDA for the year ended December 31, 2014, excludes impairment charges of $57.7 million, or $0.76 per diluted share. Net income attributable to LifePoint Health, Inc. stockholders for the year ended December 31, 2015, increased 44.3% to $181.9 million, or $3.95 per diluted share, compared with $126.1 million, or $2.69 per diluted share, for the prior year. When adjusted to exclude the bargain purchase gain and impairment charges discussed above, diluted earnings per share for the years ended December 31, 2015 and 2014, were $4.09 and $3.45, respectively. “We are pleased with our strong results for the fourth quarter, which contributed to a record 2015 for LifePoint,” said William F. Carpenter III, chairman and chief executive officer of LifePoint Health. “Overall, 2015 was a transformative year underscored by our continued progress on acquisitions, which will add approximately $1.25 billion of revenue this year. We expect that as we bring these and other recent acquisitions up to company average margins over the coming years, they will drive significant Adjusted EBITDA growth. In addition, we are confident that our continued focus on improving safety, quality, and the patient experience have differentiated our company and are fulfilling our vision of creating places where patients choose to come for care. We look forward to continuing to execute on our strategy and drive value for shareholders in 2016 and beyond.” The Company also issued the following guidance for 2016: $765 - $795 million $3.65 - $3.91 Guidance for 2016 includes the estimated impact of recent acquisitions in Columbus, Georgia, Hickory, North Carolina, Sanford, North Carolina and Columbia, South Carolina along with the Company’s other 2015 acquisitions. While the Company estimates that these acquisitions will contribute approximately $60 million to Adjusted EBITDA in 2016, combined depreciation and amortization expense and interest expense allocated to these acquisitions is estimated to exceed just over $100 million. As a result, the Company estimates that these acquisitions will have an approximate $0.60 dilutive effect on its 2016 earnings per share. The Company’s 2016 guidance also reflects a 170 basis point Adjusted EBITDA margin decline as these acquired hospitals are expected to have a combined Adjusted EBITDA margin of less than 5% in 2016. Guidance for 2016 excludes, if applicable, the estimated impact of future acquisitions, except for the aforementioned transactions, as well as the impact of items that are non-operational in nature, including items such as, but not limited to, gains or losses on early debt retirement, impairments of long-lived assets and share repurchases (if any). This guidance is also subject to certain risks, including those as set forth in the Company’s “Important Legal Information.” The Company noted that it expects its future Adjusted EBITDA margins will benefit from the integration of its 2014, 2015 and recently completed 2016 acquisitions by 100 basis points in 2017 and by an additional 100 basis points in 2018. This solely represents the expected margin contribution improvement from these acquisitions, does not reflect the impact of numerous other factors that could affect margins and, therefore, does not constitute overall consolidated Adjusted EBITDA margin guidance. A listen-only simulcast, as well as a 30-day replay, of LifePoint Health’s fourth quarter and year-end 2015 conference call will be available online at www.lifepointhealth.net/investor-relations today, Friday, February 12, 2016, beginning at 10:00 a.m. Eastern Time. LifePoint Health (NASDAQ: LPNT) is a leading healthcare company dedicated to Making Communities Healthier®. Through its subsidiaries, it provides quality inpatient, outpatient and post-acute services close to home. LifePoint owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in 22 states. It is the sole community healthcare provider in the majority of the non-urban communities it serves. More information about the Company can be found at www.LifePointHealth.net. All references to “our,” “LifePoint,” “LifePoint Health” or the “Company” used in this release refer to LifePoint Health, Inc. or its affiliates. Important Legal Information. Certain statements contained in this release, including LifePoint’s guidance for the year ended December 31, 2016, and margin improvements in acquired hospitals, are based on current management expectations and are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to qualify for the safe harbor protections from liability provided by the Private Securities Litigation Reform Act of 1995. Numerous factors exist which may cause results to differ from these expectations. Many of the factors that will determine our future results are beyond our ability to control or predict with accuracy. Such forward-looking statements reflect the current expectations and beliefs of the management of LifePoint, are not guarantees of performance and are subject to a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ from those described in the forward-looking statements. These forward-looking statements may also be subject to other risk factors and uncertainties, including without limitation: (i) the effects related to the enactment and implementation of healthcare reform, the possible enactment of additional federal or state healthcare reforms and possible changes in healthcare reform laws and other federal, state or local laws or regulations affecting the healthcare industry including the timing of the implementation of reform; (ii) the extent to which states support increases, decreases or changes in Medicaid programs, implement healthcare exchanges or alter the provision of healthcare to state residents through regulation or otherwise; (iii) delays in receiving payments for services provided, reductions in Medicare or Medicaid payments (including increased recoveries made by Recovery Audit Contractors (RAC) and similar governmental agents), compared to the timing of expanded coverage; (iv) reductions in reimbursements from commercial payors; (v) our ability to acquire healthcare facilities on favorable terms and the business risks, unknown or contingent liabilities and other costs associated therewith; (vi) our ability to successfully integrate acquired facilities into our ongoing operations and to achieve the anticipated financial results and synergies from such acquisitions, individually or in the aggregate; (vii) our ongoing ability to demonstrate meaningful use of certified electronic health record technology and recognize income for the related Medicare or Medicaid incentive payments; (viii) the deterioration in the collectability of “bad debt” and “patient due” accounts, the number of individuals without insurance coverage (or who are underinsured) who seek care at our facilities; (ix) whether our core strategies will result in anticipated operating results, including measurable quality and satisfaction improvements; (x) whether our efforts to reduce the cost of providing healthcare while increasing the quality of care are successful; (xi) the ability to attract, recruit or employ and retain qualified physicians, nurses, medical technicians and other healthcare professionals and the increasing costs associated with doing so, including the direct and indirect costs associated with employing physicians and other healthcare professionals; (xii) the loss of certain physicians in markets where such a loss can have a disproportionate impact on our facilities in such market; (xiii) the application, interpretation and enforcement of increasingly stringent and complex laws and regulations governing our operations and healthcare generally (and changing interpretations of applicable laws and regulations), related enforcement activity and the potentially adverse impact of known and unknown government investigations, litigation and other claims that may be made against us; (xiv) any interruption of or restriction in our prompt access to licensed or owned information (and information technology systems) or failure in our ability to integrate changes to LifePoint’s existing information systems or information systems of acquired facilities; (xv) adverse events in states where a large portion of our revenues are concentrated; (xvi) liabilities resulting from potential malpractice and related legal claims brought against our facilities or the healthcare providers associated with, or employed by, such facilities or affiliated entities; (xvii) our increased dependence on third parties to provide purchasing, revenue cycle and payroll services and information technology and whether they are able to do so effectively; (xviii) the continued viability of our operations through joint venture entities, the largest of which is Duke LifePoint Healthcare, our partnership with a wholly controlled affiliate of Duke University Health Systems, Inc.; and (xix) those other risks and uncertainties described from time to time in our filings with the Securities and Exchange Commission. Therefore, our future results may differ materially from those described in this release. LifePoint undertakes no obligation to update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. LIFEPOINT HEALTH, INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Dollars in millions, except per share amounts Three Months Ended December 31, Year Ended December 31, % ofRevenues % ofRevenues % ofRevenues % ofRevenues Revenues before provision for doubtful accounts Revenues LIFEPOINT HEALTH, INC. UNAUDITED EARNINGS PER SHARE CALCULATIONS In millions, except per share amounts Three Months EndedDecember 31, Year EndedDecember 31, Less: Net income attributable to noncontrolling interests and redeemable noncontrolling interests LIFEPOINT HEALTH, INC. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS Dollars in millions Dec. 31,2015 Dec. 31,2014 Accounts receivable, less allowances for doubtful accounts of $796.8 and $709.5 at December 31, 2015, and December 31, 2014, respectively LIFEPOINT HEALTH, INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Dollars in millions Three Months EndedDecember 31, Year EndedDecember 31, Adjustments to reconcile net income to net cash provided by operating activities: Increase (decrease) in cash from operating assets and liabilities, net of effects from acquisitions and divestitures: LIFEPOINT HEALTH, INC. UNAUDITED STATISTICS Three Months EndedDecember 31, Year EndedDecember 31, Change Change Consolidated: (1) -% (1) Consolidated information includes the results of our health support center, our same-hospital operations and the results of our recent acquisitions. Additionally, consolidated information includes the results of our hospitals that have previously been disposed. (2) Management and investors use equivalent admissions as a general measure of combined inpatient and outpatient volume. We compute equivalent admissions by multiplying admissions (inpatient volumes) by the outpatient factor (the sum of gross inpatient revenue and gross outpatient revenue and then dividing the resulting amount by gross inpatient revenue). The equivalent admissions computation “equates” outpatient revenue to the volume measure (admissions) used to measure inpatient volume resulting in a general measure of combined inpatient and outpatient volume. (3) Same-hospital information includes the results of our health support center and the same 63 hospitals operated during the three months ended December 31, 2015 and 2014, and the same 55 hospitals operated during the years ended December 31, 2015 and 2014. Same-hospital information excludes our hospitals that have previously been disposed. LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATIONDollars in millions Adjusted EBITDA is defined by the Company as earnings before depreciation and amortization; interest expense, net; impairment charges; other non-operating gain; provision for income taxes; and net income attributable to noncontrolling interests and redeemable noncontrolling interests. LifePoint’s management and Board of Directors use Adjusted EBITDA to evaluate the Company’s operating performance and as a measure of performance for incentive compensation purposes. LifePoint’s credit facilities use Adjusted EBITDA, subject to further permitted adjustments, for certain financial covenants. The Company believes Adjusted EBITDA is a measure of performance used by some investors, equity analysts and others to make informed investment decisions. In addition, multiples of current or projected Adjusted EBITDA are used to estimate current or prospective enterprise value. Adjusted EBITDA should not be considered as a measure of financial performance under U.S. generally accepted accounting principles (“GAAP”), and the items excluded from Adjusted EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA should not be considered in isolation or as an alternative to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the condensed consolidated financial statements as an indicator of financial performance or liquidity. Because Adjusted EBITDA is not a measurement determined in accordance with GAAP and is susceptible to varying calculations, Adjusted EBITDA as presented may not be comparable to other similarly titled measures of other companies. Three Months EndedDecember 31, Year EndedDecember 31, % ofRevenues % ofRevenues % ofRevenues % ofRevenues for doubtful accounts The following table reconciles Adjusted EBITDA as presented above to net income attributable to LifePoint Health, Inc. as reflected in the unaudited condensed consolidated statements of operations: Three Months EndedDecember 31, Year EndedDecember 31, - Net income attributable to noncontrolling interests and redeemable noncontrolling interests LIFEPOINT HEALTH, INC. UNAUDITED SUPPLEMENTAL INFORMATION (Continued) Dollars in millions, except Diluted EPS amounts The following table reconciles Estimated Adjusted EBITDA as presented for the Company’s 2016 guidance: Low End Net income attributable to noncontrolling interests and redeemable noncontrolling interests

BRENTWOOD, Tenn.--(BUSINESS WIRE)--LifePoint Health, Inc. (NASDAQ: LPNT) today announced results for the third quarter and nine months ended September 30, 2015. For the third quarter ended September 30, 2015, consolidated revenues were $1,309.5 million, up 12.3% from $1,166.0 million for the same period a year ago. Adjusted EBITDA for the third quarter ended September 30, 2015, increased 10.9% to $172.7 million compared with $155.7 million for the same period a year ago. Adjusted EBITDA for the third quarter of 2015 excludes an impairment charge of $2.2 million, or $0.03 per diluted share, related to the finalization of the net working capital settlement in connection with the divestiture of a hospital in Palatka, Florida, which was sold effective May 1, 2015. Additionally, Adjusted EBITDA for the third quarter of 2014 excludes an impairment charge of $12.2 million, or $0.16 per diluted share, for the write down of property, equipment and allocated goodwill in connection with the divestiture of a hospital in LaPlace, Louisiana, which was sold effective November 1, 2014. Including impairment charges in both periods, net income attributable to LifePoint Health, Inc. stockholders increased 58.4% to $43.6 million, or $0.94 per diluted share, compared with $27.5 million, or $0.59 per diluted share, for the same period a year ago. For the first nine months of 2015, consolidated revenues were $3,843.6 million, up 19.4% from $3,220.2 million for the same period a year ago. Adjusted EBITDA for the nine months ended September 30, 2015, increased 13.3% to $521.5 million compared with $460.2 million for the same period a year ago. Adjusted EBITDA for the nine months ended September 30, 2015 and 2014, excludes total impairment charges of $13.8 million, or $0.19 loss per diluted share, and $12.2 million, or $0.16 loss per diluted share, respectively. Including impairment charges in both periods, net income attributable to LifePoint Health, Inc. stockholders for the first nine months of 2015 increased 24.3% to $128.9 million, or $2.79 per diluted share, compared with $103.7 million, or $2.20 per diluted share, for the same period a year ago. “We are pleased with the quarter. Our operating discipline in a soft volume environment is clearly demonstrated in our results,” said William F. Carpenter III, chairman and chief executive officer of LifePoint Health. “We are excited about our acquisition strategy and the opportunity to expand margins in recently acquired hospitals. This and the significant capacity available in our balance sheet are among the factors that will allow us to continue driving shareholder value.” A listen-only simulcast, as well as a 30-day replay, of LifePoint Health’s third quarter 2015 conference call will be available on line at www.lifepointhealth.net/investor-relations today, Friday, October 30, 2015, beginning at 10:00 a.m. Eastern Time. LifePoint Health (NASDAQ: LPNT) is a leading healthcare company dedicated to Making Communities Healthier®. Through its subsidiaries, it provides quality inpatient, outpatient and post-acute services close to home. LifePoint owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in 21 states. It is the sole community healthcare provider in the majority of the non-urban communities it serves. More information about the company can be found at www.LifePointHealth.net. All references to “LifePoint,” “LifePoint Health” or the “Company” used in this release refer to LifePoint Health, Inc. or its affiliates. Important Legal Information. Certain statements contained in this release are based on current management expectations and are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to qualify for the safe harbor protections from liability provided by the Private Securities Litigation Reform Act of 1995. Numerous factors exist which may cause results to differ from these expectations. Many of the factors that will determine our future results are beyond our ability to control or predict with accuracy. Such forward-looking statements reflect the current expectations and beliefs of the management of LifePoint, are not guarantees of performance and are subject to a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ from those described in the forward-looking statements. These forward-looking statements may also be subject to other risk factors and uncertainties, including without limitation: (i) the effects related to the enactment and implementation of healthcare reform, the possible enactment of additional federal or state healthcare reforms and possible changes in healthcare reform laws and other federal, state or local laws or regulations affecting the healthcare industry including the timing of the implementation of reform; (ii) the extent to which states support increases, decreases or changes in Medicaid programs, implement healthcare exchanges or alter the provision of healthcare to state residents through regulation or otherwise; (iii) delays in receiving payments for services provided, reductions in Medicare or Medicaid payments (including increased recoveries made by Recovery Audit Contractors (RAC) and similar governmental agents), compared to the timing of expanded coverage; (iv) reductions in reimbursements from commercial payors; (v) our ability to acquire hospitals and other healthcare providers on favorable terms, the business risks and costs associated therewith and the uncertainty in operating and integrating such hospitals and other providers; (vi) our ongoing ability to demonstrate meaningful use of certified electronic health record technology and recognize income for the related Medicare or Medicaid incentive payments; (vii) the deterioration in the collectability of “bad debt” and “patient due” accounts, the number of individuals without insurance coverage (or who are underinsured) who seek care at our hospitals; (viii) whether our core strategies will result in anticipated operating results, including measurable quality and satisfaction improvements; (ix) whether our efforts to reduce the cost of providing healthcare while increasing the quality of care are successful; (x) the ability to attract, recruit or employ and retain qualified physicians, nurses, medical technicians and other healthcare professionals and the increasing costs associated with doing so, including the direct and indirect costs associated with employing physicians and other healthcare professionals; (xi) the loss of certain physicians in markets where such a loss can have a disproportionate impact on our hospital in such market; (xii) the application, interpretation and enforcement of increasingly stringent and complex laws and regulations governing our operations and healthcare generally (and changing interpretations of applicable laws and regulations), related enforcement activity and the potentially adverse impact of known and unknown government investigations, litigation and other claims that may be made against us; (xiii) any interruption of or restriction in our prompt access to licensed or owned information (and information technology systems) or failure in our ability to integrate changes to LifePoint’s existing information systems or information systems of acquired hospitals; (xiv) adverse events in states where a large portion of our revenues are concentrated; (xv) liabilities resulting from potential malpractice and related legal claims brought against our hospitals or the healthcare providers associated with, or employed by, such hospitals or affiliated entities; (xvi) our increased dependence on third parties to provide purchasing, revenue cycle and payroll services and information technology and whether they are able to do so effectively; (xvii) the continued viability of our operations through joint venture entities, the largest of which is Duke LifePoint Healthcare, our partnership with a wholly controlled affiliate of Duke University Health Systems, Inc.; and (xviii) those other risks and uncertainties described from time to time in our filings with the Securities and Exchange Commission. Therefore, our future results may differ materially from those described in this release. LifePoint undertakes no obligation to update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. All references to “our,” “LifePoint,” “LifePoint Health” and the “Company” as used throughout this release refer to LifePoint Health, Inc. and its subsidiaries. September 30, September 30, Revenues before provision for doubtful accounts Less: Net income attributable to noncontrolling interests and redeemable noncontrolling interests Less: Net income attributable to noncontrolling interests and redeemable noncontrolling interests 2015 2014 Accounts receivable, less allowances for doubtful accounts of $788.9 and $709.5 at September 30, 2015, and December 31, 2014, respectively Adjustments to reconcile net income to net cash provided by operating activities: 7.3 Increase (decrease) in cash from operating assets and liabilities, net of effects from acquisitions and divestitures: September 30, September 30, Change Change - % (1) LIFEPOINT HEALTH, INC.UNAUDITED SUPPLEMENTAL INFORMATIONDollars in millions Adjusted EBITDA is defined by the Company as earnings before depreciation and amortization; interest expense, net; impairment charges; provision for income taxes; and net income attributable to noncontrolling interests and redeemable noncontrolling interests. LifePoint’s management and Board of Directors use Adjusted EBITDA to evaluate the Company’s operating performance and as a measure of performance for incentive compensation purposes. LifePoint’s credit facilities use Adjusted EBITDA, subject to further permitted adjustments, for certain financial covenants. The Company believes Adjusted EBITDA is a measure of performance used by some investors, equity analysts and others to make informed investment decisions. In addition, multiples of current or projected Adjusted EBITDA are used to estimate current or prospective enterprise value. Adjusted EBITDA should not be considered as a measure of financial performance under U.S. generally accepted accounting principles (“GAAP”), and the items excluded from Adjusted EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA should not be considered in isolation or as an alternative to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the condensed consolidated financial statements as an indicator of financial performance or liquidity. Because Adjusted EBITDA is not a measurement determined in accordance with GAAP and is susceptible to varying calculations, Adjusted EBITDA as presented may not be comparable to other similarly titled measures of other companies. September 30, September 30, Revenues before provision for doubtful accounts The following table reconciles Adjusted EBITDA as presented above to net income attributable to LifePoint Health, Inc. as reflected in the unaudited condensed consolidated statements of operations: Net income attributable to noncontrolling interests and redeemable noncontrolling interests

BRENTWOOD, Tenn.--(BUSINESS WIRE)--LifePoint Health, Inc. (NASDAQ: LPNT) today announced results for the second quarter and six months ended June 30, 2015. For the second quarter ended June 30, 2015, consolidated revenues were $1,270.4 million, up 21.3% from $1,047.0 million for the same period a year ago. Adjusted EBITDA for the second quarter ended June 30, 2015, increased 10.3% to $175.0 million compared with $158.7 million for the same period a year ago. Net income attributable to LifePoint Health, Inc. stockholders increased 18.5% to $46.4 million, or $1.00 per diluted share, compared with $39.1 million, or $0.84 per diluted share, for the same period a year ago. For the first half of 2015, consolidated revenues were $2,534.1 million, up 23.4% from $2,054.2 million for the same period a year ago. Adjusted EBITDA for the six months ended June 30, 2015, increased 14.5% to $348.8 million compared with $304.5 million for the same period a year ago. Adjusted EBITDA for the six months ended June 30, 2015, excludes first quarter impairment charges of $11.6 million, or $0.16 per diluted share, for the write down of property, equipment, allocated goodwill and certain other assets in connection with the divestiture of a hospital in Palatka, Florida, which was sold effective May 1, 2015, and the finalization of the divestitures of three hospitals in Alabama that were sold effective January 1, 2015. Including the impairment charges, net income attributable to LifePoint Health, Inc. stockholders for the first half of 2015 increased 12.0% to $85.3 million, or $1.84 per diluted share, compared with $76.2 million, or $1.61 per diluted share, for the same period a year ago. “Our financial results for the second quarter and first half of 2015 underscore the effectiveness of our strategy,” said William F. Carpenter III, chairman and chief executive officer of LifePoint Health. “Our teams across the organization are performing well and delivering superior care to our patients, executing on our acquisition and integration plans, and managing costs effectively. We continue to pursue acquisitions in new and growing markets. We have added $1.2 billion in acquired revenue over the last two years and our pipeline remains active. All of these transactions present a significant opportunity for organic growth and margin expansion. I want to thank our physician leaders and the thousands of LifePoint employees who work hard every day to make our communities healthier.” The Company also issued the following revised guidance for 2015: Guidance includes the estimated impact of our recent acquisition in Roaring Spring, Pennsylvania, and our anticipated transactions in Flemingsburg, Kentucky, Jeffersonville, Indiana, and Watertown, Wisconsin. Guidance excludes, if applicable, the estimated impact of future acquisitions, except for the aforementioned transactions, as well as the impact of items that are non-operational in nature, including items such as, but not limited to, gains or losses on sales of hospitals and businesses, gains or losses on early debt retirement, impairments of long-lived assets and share repurchases, if any. This guidance is also subject to certain risks including those as set forth in the Company’s “Important Legal Information.” A listen-only simulcast, as well as a 30-day replay, of LifePoint Health’s second quarter 2015 conference call will be available on line at www.lifepointhealth.net/investor-relations today, Friday, July 31, 2015, beginning at 10:00 a.m. Eastern Time. LifePoint Health, Inc. is a leading healthcare company focused on providing quality healthcare services close to home. Through its subsidiaries, LifePoint operates more than 60 hospital campuses in 20 states. With a mission of “Making Communities Healthier®,” LifePoint is the sole community hospital provider in the majority of the communities it serves. More information about the Company, which is headquartered in Brentwood, Tennessee, can be found on its website, www.lifepointhealth.net. All references to “our,” “LifePoint,” “LifePoint Health,” and the “Company” as used throughout this release refer to LifePoint Health, Inc. and its subsidiaries. Important Legal Information. Certain statements contained in this release, including LifePoint’s revised guidance for the year ended December 31, 2015, are based on current management expectations and are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to qualify for the safe harbor protections from liability provided by the Private Securities Litigation Reform Act of 1995. Numerous factors exist which may cause results to differ from these expectations. Many of the factors that will determine our future results are beyond our ability to control or predict with accuracy. Such forward-looking statements reflect the current expectations and beliefs of the management of LifePoint, are not guarantees of performance and are subject to a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ from those described in the forward-looking statements. These forward-looking statements may also be subject to other risk factors and uncertainties, including without limitation: (i) the effects related to the enactment and implementation of healthcare reform, the possible enactment of additional federal or state healthcare reforms and possible changes in healthcare reform laws and other federal, state or local laws or regulations affecting the healthcare industry including the timing of the implementation of reform; (ii) the extent to which states support increases, decreases or changes in Medicaid programs, implement healthcare exchanges or alter the provision of healthcare to state residents through regulation or otherwise; (iii) delays in receiving payments for services provided, reductions in Medicare or Medicaid payments (including increased recoveries made by Recovery Audit Contractors (RAC) and similar governmental agents), compared to the timing of expanded coverage; (iv) reductions in reimbursements from commercial payors; (v) our ability to acquire hospitals and other healthcare providers on favorable terms, the business risks and costs associated therewith and the uncertainty in operating and integrating such hospitals and other providers; (vi) our ongoing ability to demonstrate meaningful use of certified electronic health record technology and recognize income for the related Medicare or Medicaid incentive payments; (vii) the deterioration in the collectability of “bad debt” and “patient due” accounts, the number of individuals without insurance coverage (or who are underinsured) who seek care at our hospitals; (viii) whether our core strategies will result in anticipated operating results, including measurable quality and satisfaction improvements; (ix) whether our efforts to reduce the cost of providing healthcare while increasing the quality of care are successful; (x) the ability to attract, recruit or employ and retain qualified physicians, nurses, medical technicians and other healthcare professionals and the increasing costs associated with doing so, including the direct and indirect costs associated with employing physicians and other healthcare professionals; (xi) the loss of certain physicians in markets where such a loss can have a disproportionate impact on our hospital in such market; (xii) the application, interpretation and enforcement of increasingly stringent and complex laws and regulations governing our operations and healthcare generally (and changing interpretations of applicable laws and regulations), related enforcement activity and the potentially adverse impact of known and unknown government investigations, litigation and other claims that may be made against us; (xiii) any interruption of or restriction in our prompt access to licensed or owned information (and information technology systems) or failure in our ability to integrate changes to LifePoint’s existing information systems or information systems of acquired hospitals; (xiv) adverse events in states where a large portion of our revenues are concentrated; (xv) liabilities resulting from potential malpractice and related legal claims brought against our hospitals or the healthcare providers associated with, or employed by, such hospitals or affiliated entities; (xvi) our increased dependence on third parties to provide purchasing, revenue cycle and payroll services and information technology and whether they are able to do so effectively; (xvii) the continued viability of our operations through joint venture entities, the largest of which is Duke LifePoint Healthcare, our partnership with a wholly controlled affiliate of Duke University Health Systems, Inc.; and (xviii) those other risks and uncertainties described from time to time in our filings with the Securities and Exchange Commission. Therefore, our future results may differ materially from those described in this release. LifePoint undertakes no obligation to update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. All references to “our,” “LifePoint,” “LifePoint Health” and the “Company” as used throughout this release refer to LifePoint Health, Inc. and its subsidiaries. LIFEPOINT HEALTH, INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Dollars in millions, except per share amounts June 30, June 30, % ofRevenues % ofRevenues % ofRevenues % ofRevenues Revenues before provision for doubtful accounts Provision for doubtful accounts Depreciation and amortization - LIFEPOINT HEALTH, INC. UNAUDITED EARNINGS PER SHARE CALCULATIONS In millions, except per share amounts Three Months EndedJune 30, Six Months EndedJune 30, and redeemable noncontrolling interests - LIFEPOINT HEALTH, INC. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS In millions June 30,2015 Dec. 31,2014 Accounts receivable, less allowances for doubtful accounts of $724.3 and $709.5 at June 30, 2015, and December 31, 2014, respectively LIFEPOINT HEALTH, INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Dollars in millions Three Months EndedJune 30, Six Months EndedJune 30, Adjustments to reconcile net income to net cash provided by operating activities: Increase (decrease) in cash from operating assets and liabilities, net of effects from acquisitions and divestitures: LIFEPOINT HEALTH, INC. UNAUDITED STATISTICS June 30, June 30, %Change %Change - - % LIFEPOINT HEALTH, INC. UNAUDITED SUPPLEMENTAL INFORMATION Dollars in millions, except Diluted EPS amounts Adjusted EBITDA is defined by the Company as earnings before depreciation and amortization; interest expense, net; impairment charges; provision for income taxes; and net income attributable to noncontrolling interests and redeemable noncontrolling interests. LifePoint’s management and Board of Directors use Adjusted EBITDA to evaluate the Company’s operating performance and as a measure of performance for incentive compensation purposes. LifePoint’s credit facilities use Adjusted EBITDA, subject to further permitted adjustments, for certain financial covenants. The Company believes Adjusted EBITDA is a measure of performance used by some investors, equity analysts and others to make informed investment decisions. In addition, multiples of current or projected Adjusted EBITDA are used to estimate current or prospective enterprise value. Adjusted EBITDA should not be considered as a measure of financial performance under U.S. generally accepted accounting principles (“GAAP”), and the items excluded from Adjusted EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA should not be considered in isolation or as an alternative to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the condensed consolidated financial statements as an indicator of financial performance or liquidity. Because Adjusted EBITDA is not a measurement determined in accordance with GAAP and is susceptible to varying calculations, Adjusted EBITDA as presented may not be comparable to other similarly titled measures of other companies. June 30, June 30, % ofRevenues % ofRevenues % ofRevenues % ofRevenues for doubtful accounts The following table reconciles Adjusted EBITDA as presented above to net income attributable to LifePoint Health, Inc. as reflected in the unaudited condensed consolidated statements of operations: Three Months EndedJune 30, Six Months EndedJune 30, redeemable noncontrolling interests The following table reconciles Adjusted EBITDA as presented for the Company’s updated guidance ranges: LowEnd HighEnd

BRENTWOOD, Tenn.--(BUSINESS WIRE)--LifePoint Hospitals, Inc. (NASDAQ: LPNT) announced today that it will provide an online Web simulcast of its first quarter 2015 conference call on Friday, May 1, 2015. The Company’s results for the first quarter ended March 31, 2015, will be released before the open of the market on Friday, May 1, 2015. The live broadcast of LifePoint Hospitals’ conference call will begin at 10:00 a.m. Eastern Time on May 1st. A 30-day online replay will be available approximately an hour following the conclusion of the live broadcast. A link to these events can be found on the Company’s website at www.lifepointhospitals.com. LifePoint Hospitals, Inc. is a leading hospital company focused on providing quality healthcare services close to home. Through its subsidiaries, LifePoint operates more than 60 hospital campuses in 21 states. With a mission of “Making Communities Healthier®,” LifePoint is the sole community hospital provider in the majority of the communities it serves. More information about the Company, which is headquartered in Brentwood, Tennessee, can be found on its website, www.LifePointHospitals.com. All references to “LifePoint,” “LifePoint Hospitals,” or the “Company” used in this release refer to LifePoint Hospitals, Inc. or its affiliates.

BRENTWOOD, Tenn.--(BUSINESS WIRE)--The fifth paragraph, first sentence of release, under the 2015 guidance table, should read: ...and an increase in the Company’s same hospital blended net revenue per equivalent admission to a range of 2.0% to 2.5% and an increase in the Company’s same hospital equivalent admissions to a range of 0.5% to 2.5% (instead of ...and an increase in blended net revenue per equivalent admission of 0.5% to 2.5%). This change has no impact on any other number or information included in the release. The corrected release reads: LIFEPOINT HOSPITALS REPORTS FOURTH QUARTER AND YEAR-END 2014 RESULTS Fourth Quarter Revenues Increased 33% Year Over Year to $1.26 Billion Company Issues 2015 Guidance LifePoint Hospitals, Inc. (NASDAQ: LPNT) today announced results for the fourth quarter and year ended December 31, 2014. For the fourth quarter ended December 31, 2014, revenues from continuing operations were $1,262.9 million, up 32.6% from $952.6 million for the same period a year ago. Adjusted EBITDA for the fourth quarter ended December 31, 2014, increased 17.2% to $174.0 million compared with $148.5 million for the same period a year ago. Adjusted EBITDA for the fourth quarter ended December 31, 2014, excludes an impairment charge of $45.5 million, or $0.60 per diluted share, for the write down of property, equipment, allocated goodwill and certain other assets in connection with the sale of three hospitals in Alabama. Including the impairment charge, income from continuing operations attributable to LifePoint Hospitals, Inc. stockholders decreased 37.5% to $22.4 million, or $0.48 per diluted share, compared with $35.9 million, or $0.75 per diluted share, for the same period a year ago. For the year ended December 31, 2014, revenues from continuing operations were $4,483.1 million, up 21.9% from $3,678.3 million for the same period a year ago. Adjusted EBITDA for 2014 increased 18.1% to $634.2 million compared with $537.0 million for the same period a year ago. Adjusted EBITDA for 2014 excludes impairment charges of $57.7 million, or $0.76 per diluted share. Including the impairment charges, income from continuing operations attributable to LifePoint Hospitals, Inc. stockholders decreased 1.3% to $126.1 million, or $2.69 per diluted share, compared with $127.8 million, or $2.68 per diluted share, for the same period a year ago. “We concluded 2014 with another quarter of solid financial performance,” said William F. Carpenter III, chairman and chief executive officer of LifePoint Hospitals. “Our differentiated strategy makes us the partner of choice for many community hospitals and is delivering strong results. In addition, we continue to develop talent, effectively manage costs and focus on quality and patient safety. These initiatives, together with our ability to capture the benefits of healthcare reform, position us well for 2015. We thank LifePoint’s talented employees and physicians, who provide our patients with high-quality care every day.” The Company also issued the following guidance for 2015: Guidance for 2015 includes the estimated receipt of $44.0 million of meaningful use funds, a $7.0 million increase from healthcare reform over 2014, and an increase in the Company’s same hospital blended net revenue per equivalent admission to a range of 2.0% to 2.5% and an increase in the Company’s same hospital equivalent admissions to a range of 0.5% to 2.5%, but does not include the impact of items, if applicable, that are non-operational in nature, including items such as, but not limited to, gains or losses on sales of hospitals and businesses, share repurchases (if any), gains or losses on early debt retirement, impairments of long-lived assets or hospital acquisitions completed in 2015. Depreciation expense for 2015 is expected to increase by approximately $30.0 million and interest expense is expected to decline by approximately $6.0 million. This guidance is also subject to certain risks, including those as set forth in the Company’s “Important Legal Information.” A listen-only simulcast, as well as a 30-day replay, of LifePoint Hospitals’ fourth quarter and year-end 2014 conference call will be available on line at www.lifepointhospitals.com/news/press-releases today, Thursday, February 12, 2015, beginning at 10:00 a.m. Eastern Time. LifePoint Hospitals, Inc. is a leading hospital company focused on providing quality healthcare services close to home. Through its subsidiaries, LifePoint operates 65 hospital campuses in 21 states. With a mission of “Making Communities Healthier®,” LifePoint is the sole community hospital provider in the majority of the communities it serves. More information about the Company, which is headquartered in Brentwood, Tennessee, can be found on its website, www.LifePointHospitals.com. All references to “LifePoint,” “LifePoint Hospitals,” or the “Company” used in this release refer to LifePoint Hospitals, Inc. or its affiliates. Important Legal Information. Certain statements contained in this release, including LifePoint’s guidance for the year ended December 31, 2015, are based on current management expectations and are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to qualify for the safe harbor protections from liability provided by the Private Securities Litigation Reform Act of 1995. Numerous factors exist which may cause results to differ from these expectations. Many of the factors that will determine our future results are beyond our ability to control or predict with accuracy. Such forward-looking statements reflect the current expectations and beliefs of the management of LifePoint, are not guarantees of performance and are subject to a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ from those described in the forward-looking statements. These forward-looking statements may also be subject to other risk factors and uncertainties, including without limitation: (i) the effects related to the enactment and implementation of healthcare reform, the possible enactment of additional federal or state healthcare reforms and possible changes in healthcare reform laws and other federal, state or local laws or regulations affecting the healthcare industry including the timing of the implementation of reform; (ii) the extent to which states support increases, decreases or changes in Medicaid programs, implement healthcare exchanges or alter the provision of healthcare to state residents through regulation or otherwise; (iii) delays in receiving payments for services provided, reductions in Medicare or Medicaid payments (including increased recoveries made by Recovery Audit Contractors (RAC) and similar governmental agents), compared to the timing of expanded coverage; (iv) reductions in reimbursements from commercial payors; (v) our ability to acquire hospitals and other healthcare providers on favorable terms, the business risks and costs associated therewith and the uncertainty in operating and integrating such hospitals and other providers; (vi) our ongoing ability to demonstrate meaningful use of certified electronic health record technology and recognize income for the related Medicare or Medicaid incentive payments; (vii) the deterioration in the collectability of “bad debt” and “patient due” accounts, the number of individuals without insurance coverage (or who are underinsured) who seek care at our hospitals; (viii) whether our core strategies will result in anticipated operating results, including measurable quality and satisfaction improvements; (ix) whether our efforts to reduce the cost of providing healthcare while increasing the quality of care are successful; (x) the ability to attract, recruit or employ and retain qualified physicians, nurses, medical technicians and other healthcare professionals and the increasing costs associated with doing so, including the direct and indirect costs associated with employing physicians and other healthcare professionals; (xi) the loss of certain physicians in markets where such a loss can have a disproportionate impact on our hospital in such market; (xii) the application, interpretation and enforcement of increasingly stringent and complex laws and regulations governing our operations and healthcare generally (and changing interpretations of applicable laws and regulations), related enforcement activity and the potentially adverse impact of known and unknown government investigations, litigation and other claims that may be made against us; (xiii) any interruption of or restriction in our prompt access to licensed or owned information (and information technology systems) or failure in our ability to integrate changes to LifePoint’s existing information systems or information systems of acquired hospitals; (xiv) adverse events in states where a large portion of our revenues are concentrated; (xv) liabilities resulting from potential malpractice and related legal claims brought against our hospitals or the healthcare providers associated with, or employed by, such hospitals or affiliated entities; (xvi) our increased dependence on third parties to provide purchasing, revenue cycle and payroll services and information technology and whether they are able to do so effectively; (xvii) the continued viability of our operations through joint venture entities, the largest of which is Duke LifePoint Healthcare, our partnership with a wholly controlled affiliate of Duke University Health Systems, Inc.; and (xviii) those other risks and uncertainties described from time to time in our filings with the Securities and Exchange Commission. Therefore, our future results may differ materially from those described in this release. LifePoint undertakes no obligation to update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. All references to “our,” “LifePoint,” “LifePoint Hospitals” and the “Company” as used throughout this release refer to LifePoint Hospitals, Inc. and its subsidiaries. LIFEPOINT HOSPITALS, INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Dollars in millions, except per share amounts December 31, December 31, % ofRevenues % ofRevenues % ofRevenues % ofRevenues income taxes net of income taxes LIFEPOINT HOSPITALS, INC. UNAUDITED EARNINGS PER SHARE CALCULATIONS In millions, except per share amounts and redeemable noncontrolling interests LifePoint Hospitals, Inc. stockholders LIFEPOINT HOSPITALS, INC. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS In millions 2014 2013 Accounts receivable, less allowances for doubtful accounts of $709.5 and $741.2 at December 31, 2014 and December 31, 2013, respectively LIFEPOINT HOSPITALS, INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Dollars in millions Three Months EndedDecember 31, Year Ended December 31, 2014 2013 2014 2013 Adjustments to reconcile net income to net cash provided by operating activities: Increase (decrease) in cash from operating assets and liabilities, net of effects from acquisitions and divestitures: LIFEPOINT HOSPITALS, INC. UNAUDITED STATISTICS Three Months EndedDecember 31, Year EndedDecember 31, %Change %Change (1) Continuing operations information includes the results of our hospital support center, our same-hospital operations and the results of our recent acquisitions completed in 2014 and 2013. Additionally, continuing operations information includes the results of River Parishes Hospital, which was sold effective November 1, 2014, and Lakeland Community Hospital, Northwest Medical Center and Russellville Hospital, which were sold effective January 1, 2015. (2) Management and investors use equivalent admissions as a general measure of combined inpatient and outpatient volume. We compute equivalent admissions by multiplying admissions (inpatient volumes) by the outpatient factor (the sum of gross inpatient revenue and gross outpatient revenue and then dividing the resulting amount by gross inpatient revenue). The equivalent admissions computation “equates” outpatient revenue to the volume measure (admissions) used to measure inpatient volume resulting in a general measure of combined inpatient and outpatient volume. (3) Same-hospital information includes the results of our hospital support center and the same 53 hospitals operated during the years ended December 31, 2014 and 2013. Same-hospital information excludes the results of our recent acquisitions completed in 2014 and 2013, with the exception of Scott Memorial Hospital, which we acquired effective January 1, 2013, through our joint venture with Norton Healthcare, Inc. and which is included in our same-hospital information. Additionally, same-hospital information excludes our hospitals that have previously been disposed, in addition to Lakeland Community Hospital, Northwest Medical Center and Russellville Hospital, which were sold effective January 1, 2015. LIFEPOINT HOSPITALS, INC.UNAUDITED SUPPLEMENTAL INFORMATIONDollars in millions, except Diluted EPS amounts Adjusted EBITDA is defined by the Company as earnings before depreciation and amortization; interest expense, net; impairment charges; debt transaction costs; gain on settlement of pre-acquisition contingent obligation; provision for income taxes; loss (income) from discontinued operations, net of income taxes; and net income attributable to noncontrolling interests and redeemable noncontrolling interests. LifePoint’s management and Board of Directors use Adjusted EBITDA to evaluate the Company’s operating performance and as a measure of performance for incentive compensation purposes. LifePoint’s credit facilities use Adjusted EBITDA, subject to further permitted adjustments, for certain financial covenants. The Company believes Adjusted EBITDA is a measure of performance used by some investors, equity analysts and others to make informed investment decisions. In addition, multiples of current or projected Adjusted EBITDA are used to estimate current or prospective enterprise value. Adjusted EBITDA should not be considered as a measure of financial performance under U.S. generally accepted accounting principles (“GAAP”), and the items excluded from Adjusted EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA should not be considered in isolation or as an alternative to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the condensed consolidated financial statements as an indicator of financial performance or liquidity. Because Adjusted EBITDA is not a measurement determined in accordance with GAAP and is susceptible to varying calculations, Adjusted EBITDA as presented may not be comparable to other similarly titled measures of other companies. December 31, December 31, % ofRevenues % ofRevenues % ofRevenues % ofRevenues for doubtful accounts The following table reconciles Adjusted EBITDA as presented above to net income attributable to LifePoint Hospitals, Inc. as reflected in the unaudited condensed consolidated statements of operations: Three Months EndedDecember 31, Year EndedDecember 31, Net income attributable to noncontrolling interests and redeemable noncontrolling interests LIFEPOINT HOSPITALS, INC. UNAUDITED SUPPLEMENTAL INFORMATION (Continued) Dollars in millions, except Diluted EPS amounts The following table reconciles Estimated Adjusted EBITDA as presented for the Company’s 2015 guidance: LowEnd HighEnd

BRENTWOOD, Tenn.--(BUSINESS WIRE)--LifePoint Hospitals, Inc. (NASDAQ: LPNT) announced today that it will provide an online Web simulcast of its fourth quarter and year-end 2014 conference call on Thursday, February 12, 2015. The Company’s results for the fourth quarter and year ended December 31, 2014, will be released before the open of the market on Thursday, February 12, 2015. The live broadcast of LifePoint Hospitals’ conference call will begin at 10:00 a.m. Eastern Time on February 12th. A 30-day online replay will be available approximately an hour following the conclusion of the live broadcast. A link to these events can be found on the Company’s website at www.lifepointhospitals.com. LifePoint Hospitals, Inc. is a leading hospital company focused on providing quality healthcare services close to home. Through its subsidiaries, LifePoint operates 64 hospital campuses in 21 states. With a mission of “Making Communities Healthier®,” LifePoint is the sole community hospital provider in the majority of the communities it serves. More information about the Company, which is headquartered in Brentwood, Tennessee, can be found on its website, www.LifePointHospitals.com. All references to “LifePoint,” “LifePoint Hospitals,” or the “Company” used in this release refer to LifePoint Hospitals, Inc. or its affiliates.

BRENTWOOD, Tenn.--(BUSINESS WIRE)--LifePoint Hospitals, Inc. (NASDAQ: LPNT) announced today that it will provide an online Web simulcast of its third quarter 2014 conference call on Friday, October 24, 2014. The Company’s results for the third quarter ended September 30, 2014, will be released before the open of the market on Friday, October 24, 2014. The live broadcast of LifePoint Hospitals’ conference call will begin at 10:00 a.m. Eastern Time on October 24th. A 30-day online replay will be available approximately an hour following the conclusion of the live broadcast. A link to these events can be found on the Company’s website at www.lifepointhospitals.com. LifePoint Hospitals, Inc. is a leading hospital company focused on providing quality healthcare services close to home. Through its subsidiaries, LifePoint operates 68 hospital campuses in 21 states. With a mission of “Making Communities Healthier®,” LifePoint is the sole community hospital provider in the majority of the communities it serves. More information about the Company, which is headquartered in Brentwood, Tennessee, can be found on its website, www.LifePointHospitals.com. All references to “LifePoint,” “LifePoint Hospitals,” or the “Company” used in this release refer to LifePoint Hospitals, Inc. or its affiliates.